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Disclaimer 
This report was prepared as an account of work sponsored by an agency of the United States Government.  
Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, 
express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of 
any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately 
owned rights.  Reference herein to any specific commercial product, process, or service by trade name, trademark, 
manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favoring 
by the United States Government or any agency thereof.  The views and opinions of authors expressed herein do 
not necessarily state or reflect those of the United States Government or any agency thereof. 
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Abstract 
The main objectives of this three-year research project are: 1) to employ the latest advances in 
genetics and bioengineering, especially Directed Protein Evolution technology, to improve the 
effectiveness of the microbial enhanced oil recovery (MEOR) process. 2) to improve the surfactant 
activity and the thermal stability of bio-surfactant systems for MEOR; and 3) to develop improved 
laboratory methods and tools that screen quickly candidate bio-systems for EOR.   
Biosurfactants have been receiving increasing attention as Enhanced Oil Recovery (EOR) 
agents because of their unique properties (i.e., mild production conditions, lower toxicity, and 
higher biodegradability) compared to their synthetic chemical counterparts. Rhamnolipid as a potent 
natural biosurfactant has a wide range of potential applications, including EOR and bioremediation.   
During the three-year of the project period, we have successfully cloned the genes involved in the 
rhamnolipid bio-synthesis. And by using the Transposon containing Rhamnosyltransferase gene 
rhlAB, we engineered the new mutant strains P. aeruginosa PEER02 and E. coli TnERAB so they 
can produce rhamnolipid biosurfactans. We were able to produce rhamnolipds in both P. 
aeroginosa PAO1-RhlA- strain and P. fluorescens ATCC15453 strain, with the increase of 55 to 
175 fold in rhamnolipid production comparing with wild type bacteria strain. We have also 
completed the first round direct evolution studies using Error-prone PCR technique and have 
constructed the library of RhlAB-containing Transposon to express mutant gene in heterologous 
hosts. Several methods, such as colorimetric agar plate assay, colorimetric spectrophotometer assay, 
bioactive assay and oil spreading assay have been established to detect and screen rhamnolipid 
production.  
 Our engineered P. aeruginosa PEER02 strain can produce rhamnolipids with different 
carbon sources as substrate. Interfacial tension analysis (IFT) showed that different rhamnolipids 
from different substrates gave different performance. Those rhamnolipids with plant oil as substrate 
showed as low an IFT as 0.05mN/m in the buffer solution with pH5.0 and 2% NaCl. Core flooding 
tests showed that rhamnolipids produced by our engineered bacteria are effective agents for EOR.  
At 250ppm rhamnolipid concentration from P. aeruginosa PEER02, 42% of the remaining oil after 
waterflood was recovered. These results were therefore significant towards considering the 
exploration of the studied rhamnolipids as EOR agents. 
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4. EXECUTIVE SUMMARY 
This report summarizes the research work performed and results of this 3-year project. The main 
objectives are to employ the latest bioengineering technologies to develop manufacturing methods 
at the surface that can create more cost-effective surfactants for the chemical flood EOR process; 
and to improve the surfactant activity and the thermal stability of bio-surfactant systems deployed 
subsurface for MEOR.  Other objectives are to develop improved laboratory methods and tools that 
screen quickly candidate bio-systems for EOR.  These detailed laboratory procedures to identify 
effectively and quickly mutated genes for their bio-surfactant activity and thermal stability is a 
substantial effort.  Documenting these procedures will accelerate greatly the development of yet 
newer bio-systems for improved oil recovery applications in similar, future studies. 
 
During the three-year project period,  
1.  We have successfully cloned the genes involved in the rhamnolipid bio-synthesis. And by using 
the Transposon containing Rhamnosyltransferase gene rhlAB, we have successfully produced 
rhamnolipds in both P. aeroginosa PAO1-RhlA- cells and E.coli cells, with the increase of 55 to 
175 fold in rhamnolipid production compared with wild type bacteria strain.  
2. We have completed the several round direct evolution studies using Error-prone PCR technique 
and have constructed the library of RhlAB-containing Transposon to express mutant genes in 
heterologous hosts. 
3. We successfully engineered the new mutant strains P. aeruginosa PEER02 and E. coli TnERAB 
so they can produce rhamnolipid biosurfactans.  LC-MS spectrum showed the structure of purified 
rhamnolipids from P. aeruginosa PEER02 was similar to those from other P. aeruginosa strains, 
but have different percentage for each component. The main component of purified rhamnolipids 
from E. coli TnERAB is C10-C10 with monorhamnose (2 alkyl chains, each with 10 carbons, and a 
single rhamnose head group).  
4. Core flooding tests showed that rhamnolipids produced by our engineered bacteria are effective 
agents for EOR.  At 250ppm rhamnolipid concentration from P. aeruginosa PEER02, 42% of the 
remaining oil after waterflood was recovered. These results were therefore important for 
considering the exploration of the studied rhamnolipids as EOR agents.   
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5. Our engineered P. aeruginosa PEER02 strain can produce rhamnolipids with different carbon 
sources as substrate. Interfacial tension analysis (IFT) showed that different rhamnolipids from 
different substrates gave different performance. Those rhamnolipids with plant oil as substrate 
showed as low an IFT as 0.05mN/m in the buffer solution with pH5.0 and 2% NaCl. Fed-batch 
fermentation with soybean oil as substrate greatly enhanced the production of rhamnolipids, and the 
yield reached about 25g/L.These results showed some potential for producing high-performance 
rhamnolipids with high yield from low-cost renewable resources. 
6. Through the methodology of synthetic biology and metabolic engineering, we engineered E. coli 
strains harboring various gene combinations from P. aeruginosa and successfully produced either 
mono-rhamnolipids or di-rhamnolipids (one or two head groups).  Engineered rhamnolipids showed 
different performance in interfacial tension and antimicrobial activity. LC-MS analysis confirmed 
they mainly contained C10-C10 (2 alkyl chains, each with 10 carbons) and C10-C8 (2 alkyl chains, 
one with 10 carbons and the other with 8 carbons) carbon chain as well as carbon chains with other 
lengths in small percentages.  
7. A mutant with different product selectivity was found via directed evolution and subsequent 
high-throughput screening. Compared with the wild-type strain, the mutant almost produced 
rhamnolipids with only C10-C10 carbon chain. 
We have applied the latest scientific methods in directed protein evolution technology and 
microbiology to create superior bio-systems that will be highly effective in producing bio-
surfactant.  We reached the following scientific breakthroughs:  
• A first application of genetic bioengineering to create a chemical product for oil and 
gas production operations. 
• Advancement of our understanding of the mechanisms of the bacteria responsible for 
the manufacture of bio-surfactants of interest to industry 
Engineering-based breakthroughs include:  
• New bio-systems to produce surfactants that could reduce the cost of conventional 
surfactant flooding. 
• New bio-systems for MEOR applications that generate greater amounts of bio-
surfactant and could thrive in more severe reservoir conditions.  
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• A proven methodology to evaluate rapidly other candidate bio-systems to create 
other bio-surfactants.   
• By demonstrating success here with this general approach of genetic engineering, it 
will promote bio-production of yet other types of oilfield chemicals.  
 
5. INTRODUCTION  
 
This report provides a summary of the entire 3-year project. The main objective is to employ the 
latest advances in genetics and bioengineering, especially the Directed Protein Evolution 
technology, to improve the effectiveness of the MEOR process. 
 
5.1 Background 
 As we all know, there is a finite limit to the amount of fossil fuel.  After more than a century 
of exploration, it is more and more difficult to find new hydrocarbon reservoirs, and from the 
existing reservoirs, less and less reserves are available. Therefore, in order to maintain the current 
rate of production and to provide adequate supply to the US consumers and industry for increasing 
demand, we must find new ways to increase hydrocarbon production while the amount of reserves 
keeps dwindling. This is truly a paradox, and a scientific topic of immense economic and national 
security implications.  For example, in US we now import well over half of the oil consumed in 
order to meet current demand.   
Most oil is produced in two phases: primary and secondary recovery. During primary 
recovery, the natural pressure of the reservoir drives oil into the wellbore, and artificial lift 
techniques (such as pumps) bring the oil to the surface. Only about 10 percent of a reservoir’s 
original oil is typically produced during primary recovery. For over 50 years producers have 
employed secondary recovery techniques, usually by injecting water to displace oil, to extend the 
productive life of oil fields, often increasing ultimate recovery to 20 – 40 percent.  Regarding 
natural gas, the US has maintained sufficient production for domestic use, but this has been due to a 
spike in the prices that can support increased drilling activity, plus a significant increase in 
producing now “unconventional” gas resources such as from “tight’ sandstones, and shale 
formations, and coal beds.    
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Hydrocarbon producers have aggressive programs in place to drill more wells, plus conduct 
well stimulation operations (e.g. fracturing, acid and solvents to clean wells, etc.) designed to 
remove material impeding oil and gas flow to the surface, and provide flow channels of high 
permeability in order to extract more hydrocarbons faster.  Chemicals (e.g. surfactants and 
polymers) added to these stimulation fluids are a key to having successful results at treated wells in 
these EOR technologies by these additives controlling fluid properties (e.g. surface tension) and 
solid/mineral interactions (e.g. fluid wetting).  Schlumberger, Halliburton, and BJ Services, for 
example, are major corporations that provide these well treatment technologies to the oil and gas 
producers. The market in oil field chemistry to support EOR and other routine oil field activities is 
about $4 billion/yr and growing.      
If bio-surfactants can be manufactured at a low cost, then this offers us the capability of 
creating a new generation of high performance surfactant formulations for immediate use in oil and 
gas production operations for MEOR.  Such bio-based surfactant formulations would have several 
potential advantages over using the current generation of synthetic surfactants:  1) lower cost, 2) 
customized chemical structure for better performance characteristics for target EOR applications, 3) 
created from renewable resources instead of petroleum, 4) inherently more environmentally 
friendly. 
Beyond the immediate need and growing opportunity to make the current hydrocarbon 
production operations more efficient by deploying low cost bio-surfactants, an enormous, but future 
“step change” opportunity is so-called tertiary or EOR.  Even with using the best practices in 
conventional primary and secondary recovery operations, there is usually left two-thirds of the oil in 
the reservoir.  In the United States, the resource of crude oil totals 649 billion barrels (NOTE: 1 
barrel = 42 gallons). This resource consists of 183 billion barrels of cumulative production, 22 
billion barrels of proven reserves, 67 billion barrels of undiscovered reserves and 377 billion 
barrels are still remaining in discovered reserves (Figure 5-1-1). The 377 billion barrels, 
represents 2/3 of the crude oil that is trapped in already discovered oil reserves after primary and 
secondary conventional productions have been completed. However, further recovery of this 
trapped oil is challenging because the remaining oil is often located in regions of the reservoir that 
are difficult to access, and the oil is trapped in the micron-size pores of reservoir rock by high 
capillary forces.   
Different EOR methods to mobilize remaining oil such as injection of steam, carbon 
dioxide, and surfactant/polymer chemicals have the capability of recovering perhaps another 20 
percent of the oil that was originally in place.  The fluid volumes to conduct an EOR operation are 
immense because they must displace (“flood”) an entire reservoir (millions of barrels).  For 
example, to process a medium size reservoir to recover 100 million barrels of oil might require 
injection of 500 million pounds of synthetic surfactant spread throughout 300 million barrels of 
fluid.   
   
 
Figure 5-1-1. US oil reserves that are target for Enhanced Oil Recovery  
 
Surfactant based EOR has potential to address a significant fraction of this future 377 billion 
bbl target, and more attractively, this method targets premium quality light crude oil.  Worldwide, 
the Society of Petroleum Engineers (SPE) estimate the potential resource for EOR is 2 trillion 
barrels (Thomas, 2006), and that much of that is recoverable by chemical methods.   
The chemical material cost is perhaps the main factor controlling the profitability (and main 
barrier to widespread commercial implementation, Wu 1996, Taber 1996).  An inherent potential 
advantage of a biological approach is that we can make surfactants whose costs are decoupled from 
the price of crude oil.  The nutrients and other raw materials to create bio-surfactants do not have to 
be petroleum-based, and in fact potentially may come from waste streams.  Commercial synthetic 
surfactants invariably are more expensive than the crude oil from which they are derived.    
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Even with the current, high price of synthetic surfactants, there is a huge potential global 
demand from conventional chemical flooding.  For example, in China alone, it is estimated that 
roughly 30 billion pounds of surfactant could be required to meet their future EOR objective of 
several billion barrels of incremental oil production (Liu, 2001).  Also, Chevron is planning an 
expanded field test of surfactant EOR in their Minas Field, which would require over a billion 
pounds of surfactant at full commercial scale (Bou-Mikael, 2000).  So capturing even a small 
fraction of this potential market with low cost bio-surfactants would represent a new billion pound 
chemical product.      
Finally, an even another longer-range option for us is to supply customized bacteria for 
MEOR as another EOR technology.  In this case active bacteria are injected directly into an oil 
reservoir, and these bacteria in turn generate in-situ surfactants, polymers, and gases that can induce 
additional oil recovery.  It is estimated by DOE that 46 percent of the US domestic reservoirs with 
original oil in place that exceeds 20 billion barrels could be candidates for MEOR.  Several studies 
have had promising results, with bio-systems in MEOR laboratory tests recovering typically of 10 – 
20% of water flood incremental oil (Yonebayashi, 1997). 
For EOR applications, chemical surfactants cost in range of $1 to $3 per pound, whereas 
lignin-based sulfonates are cheaper.  But the current cost of bio-surfactants may be about 3 to 10 
times higher using current technology (Desai and Banat, 1997).  Attempts have been made to 
improve overall process economics in bio-surfactant production.  Those efforts have been focused 
on searching for cheap substrates, increasing the productivity by manipulating physiological 
conditions, mixing multiple microbial cultures, and modifying the downstream recovery processes.  
Potential overall improvements via these strategies are limited. 
 
Technical Barriers and Need of our Research 
 
The fermentative (microbiological) production of value added chemicals from agriculture biomass-
derived substrates is the historical essence of industrial biotechnology.  One such value added 
product that can be produced by microorganisms is a structurally diverse group of surface-active 
molecules named biosurfactant. These molecules reduce surface and interfacial tensions in both 
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aqueous solutions and hydrocarbon mixtures, which makes them good candidates for our target 
EOR use and other oil field applications. In the past few decades, biosurfactants have gained more 
and more attention because they have many advantages over the chemical surfactants, such as 
biodegradability; lower toxicity; better environmental compatibility; higher selectivity and specific 
activity at extreme temperatures, pH and salinity; and the ability to be synthesized from renewable 
feedstocks. However, the widespread use of biosurfactants has yet to be seen because of the several 
technological barriers that have limited the large scale production of the biosurfactants and the lack 
of state-of-the-art applications that utilize biosurfactants.  
Barrier 1.   High manufacturing costs of biosurfactants 
For EOR applications, chemical surfactants cost in range of $1 to $3 per pound, whereas 
lignin-based sulfonates are cheaper.  But the current cost of bio-surfactants may be about 3 to 10 
times higher using current technology (Desai and Banat, 1997).  Attempts have been made to 
improve overall process economics in bio-surfactant production.  Those efforts have been focused 
on searching for cheap substrates, increasing the productivity by manipulating physiological 
conditions, mixing multiple microbial cultures, and modifying the downstream recovery processes.  
Potential overall improvements via these strategies are quite limited. Recent developments in the 
biotechnology area have provided us new ways to target this problem.  
 
Barrier 2.  Lack of high performance biosurfactants that could functionally replace and surpass the 
conventional surfactants for oilfield applications.  
 
Developing effective EOR applications can be very challenging because of the complexity of the oil 
reservoirs environment, such as big differences in temperature, pH and salinity, and because of the 
complexity of the chemical and physical property of the crude oils, such as huge viscosity 
differences. There has been a need for varieties of surfactants for different EOR applications, and 
many special performance synthetic surfactants have been created for this purpose. Obviously, in 
order for biosurfactants to be used in widespread EOR applications, we also need to produce 
biosurfactants with diverse physical properties, especially superior functionalities over their 
synthetic counterparts. However, relying on discover of different naturally existing bacteria strains 
to produce biosurfactants with diverse functions is slow and insufficient. Again, modern 
biotechnology, such as Directed Evolution Technology, has provided us a solution. 
The rhamnolipid biosurfactants have been studied extensively (Liang and Wullbrandt, 
1999).  Rhamnolipid is produced as mixtures in various proportions, including one or two 
rhamnoses attached to β-hydroxyalkanoic acid (Soberon-Chavez et al., 2005).  The lengths of the 
fatty acid chains of rhamnolipid vary significantly, resulting in a multitude of different rhamnolipid 
congeners.  This includes fatty acyl chains with lengths of 8, 10, 12, and 14 carbons, as well as of 
12- or 14-carbon chains with a single double-bond (Figure 5-1-2).  The type of rhamnolipid 
produced depends on the bacterial strain, the carbon source used, and the process strategy (Robert et 
al., 1989; Mulligan et al., 1993).  Rhamnolipid induces a remarkably larger reduction in the surface 
tension of water from 72 to values below 30mN/m and it reduces the interfacial tension of water/oil 
systems from 43mN/m to values below 1mN/m.  Rhamnolipid also has an excellent emulsifying 
power with a variety of hydrocarbons and vegetable oils (Abalos et al., 2001). 
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Figure 5-1-2. Structure of rhamnolipids produced by P. aeruginosa. Left: mono-rhamnolipid; Right: 
di-rhamnolipid. Alkyl chain length may vary. (In shorthand, mono-rhamnolipid: Rha-Cm+4-C n+4, di-
rhamnolipid: Rha- Rha-Cm+4-C n+4, m, n=4-8) 
 
The increasing ecological concern with using synthetic chemical surfactants has led us to 
propose rhamnolipid as environmentally benign substitute, although it will be necessary to reduce 
production costs.  The use of renewable low-cost substrates, such as plant oil and grain starch, and 
even lignocellulosic biomass, could dramatically increase the economics of rhamnolipid production 
(Nitschke et al., 2005; Mukherjee et al., 2006).  Many bacteria, especially Pseudomonads, can 
utilize efficiently renewable low-cost substrates, but they either lack the ability to biosynthesize the 
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rhamnolipid, or only have very low yield of rhamnolipid.  Therefore, we could use advanced 
molecular biotechniques to bioengineer renewable substrate-consuming bacteria that produce 
inexpensive rhamnolipid with high yield.   
The main purpose of our research is to employ advanced bioengineering methods to 
engineer bacteria with the capability to produce biosurfactant with much greater activity than at 
present.  And because these biosurfactants materials are to be used in the oilfield, there is much less 
concern with the purity, color, etc. of the produced product.  We can save on much of the expense 
normally associated with product separation and purification by accepting a less refined product for 
oilfield use.  Therefore, the biosurfactant manufacture can be established at or near a target oil field, 
then the supernatant solution containing the chemical may be a sufficiently concentrated product as 
is (there is little or no transportation cost, hence excess water in the product is not a factor for this 
strategy.)  Furthermore, by optimizing the engineered the bacteria using cheap agriculture 
substrates, such as plant oils, as nutrients to produce biosurfactants, it could further drive down the 
cost of manufacturing biosurfactants, making them more competitive with the conventional 
surfactants.   
 
6. Experimental Procedures and Methods 
Bacterial strain, media and chemicals 
The strains and plasmids used in this study were summarized in Table S1 (see supplemental 
materials). Briefly, P. aeroginosa PAO1-RhlA- (Rahim et al, 2001) and E. coli BL21(DE3) were 
the parental strains for engineering rhamnolipid production.  E. coli DH5 was the host strain for 
constructing various recombinant plasmids.  The E. coli strains were commercially available.  
Except for rhamnolipid fermentation, all these bacteria were grown on LB (Luria-Bertani) media 
containing suitable antibiotics at 37 ºC (Sambrook and Russell, 2001). Unless noted otherwise, 
antibiotics were used at the following concentration: chloramphenicol, 100 mg/mL for P. 
aeruginosa and 25 mg/mL for E. coli; ampicillin, 50 mg/mL for E. coli; kanamycin, 40 mg/mL for 
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E. coli.  All enzymes used for DNA manipulation were purchased from New England Biolabs 
(Beverly, MA).  EZ::TN™ Transposase was purchased from EPICENTRE Biotechnologies 
(Madison, WI). 
Fermentation media and conditions 
Nutrient broth from BD (Becton, Dickinson and Company, Franklin Lakes, NJ) was used for seed 
culture of P. aeruginosa and LB for seed culture of E. coli. The mineral salt (MS) medium 
supplemented 0.4% or 2% glucose or 2% soybean oil as carbon source was the rhamnolipid 
fermentation medium. The MS medium contained (per L): 15 g NaNO3; 1.1 g KCl; 1.1 g NaCl; 
0.00028 g FeSO4⋅7H2O; 3.4 g KH2PO4; 4.4 g K2HPO4; 0.5 g MgSO4⋅7H2O; 0.5 g yeast extract; and 
5 ml of a trace element solution containing (per L): 0.29 g ZnSO4⋅7H2O; 0.24 g CaCl2⋅4H2O; 0.25 g 
CuSO4⋅5H2O; and 0.17 g MnSO4⋅H2O, (Lindhardt et al, 1989).  The trace element solution was 
filter-sterilized through a 0.2-µm membrane filter (Millipore, type GS) and then added to the 
medium, which had been autoclaved and allowed to cool. 
P. aeruginosa wild-type and mutant were first grown in nutrient broth for 24 h at 30ºC with 
shaking and then diluted 1:10 into MS medium plus 2% glucose or soybean oil and incubated for 4 
days.  E. coli wild-type and mutant were first grown in LB for 24h at 30ºC with shaking and then 
diluted 1:10 into MS or LB media plus 0.4% glucose supplemented 50mM IPTG as inducer and 
incubated for 24 h.  Incubation was carried out in 250-mL Erlenmeyer flask with 25 mL medium 
and at 30ºC with orbital shaking at 250 rpm. 
Plasmid and strain construction 
The pMOD-2C derived from pMOD-2 (EPICENTRE Biotechnologies Madison, WI) was for 
constructing artificial transposon. The pACYC184 was digested with XbaI and StyI to produce a 
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chloramphenicol resistant cassette. After being blunted with T4 DNA polymerase, this 
chloramphenicol resistant cassette was inserted into the SmaI site of pMOD2 to produce pMOD-2C.  
Rhamnosyltransferase 1 complex gene RhlAB with native operon promoter was amplified with 
primers RhlAB-1a (5’- CCCAATCTCTAGATGCCTTTTCCGCCAACCCCTCGCTG-3’) and 
RhlAB-2 (5'-AACCAAGCT TTCAGGACGCAGCCTTCAGCCATCG-3') and P. aeruginosa 
PA01 genomic DNA (purchased from American Type Culture Collection) as template; PCR 
product of RhlAB was digested with XbaI and HindIII and cloned into pMOD-2C to produce the 
recombinant plasmid pMOD-2CRABa.  3.5kb chimeric transposon TnRABa with native operon 
promoter was produced by digesting pMOD-2CRABa with PshAI. Coding sequence of 
rhamnosyltransferase 1 complex RhlAB was amplified with primers RhlAB-1b (5’-
AGTTGGTACCATG CGGCGCGAAAGTCTGTTGG-3’) and RhlAB-2 (5'-
AACCAAGCTTTCAGGACGCAGCCTTCA GCCATCG-3'); PCR product was digested with 
KpnI and HindIII and cloned into pET30a(+) to produce the recombinant plasmid pETRAB.  2.4kb 
SphI-HindIII fragment from pETRAB was cloned into pMOD-2C to produce the recombinant 
plasmid pMOD-2CRABb (In this case, SphI in the fragment and XbaI in pMOD-2C were blunted 
first, then ligated).  Chimeric transposon TnRABb with T7 promoter was produced by digesting 
pMOD-2CRABb with PshAI (Figure 6-1-1).  Transponon TnRABa or TnRABb was incubated with 
EZ::TN™ Transposase in the absence of Mg2+ to produce transposome TnRABasome or 
TnRABbsome (Figure 6-1-2) that was transformed into P. aeruginosa PAO1-RhlA- or E. coili 
BL21(DE3) by electroporation (Smith and Iglewski, 1989), respectively (Figure 6-1-3).  After 
genotypic and phenotypic analysis, engineered strains P. aeruginosa PEER02 and E. coli TnRAB 
were constructed and ready for rhamnolipid production. 
Mapping of transposon insertion site 
Five micrograms of transposant (P. aeruginosa PEER02 or E. coli TnERAB) genomic DNA was 
digested with TaqI and then circularized in a ligation reaction using T4 DNA ligase at a DNA 
concentration of 5 ng/μL. Ligation products were purified with UltraClean™ 15 DNA Purification 
Kit (Mo Bio Laboratories, Carlsbad, CA) and resuspended in water at 10 ng/μL. Inverse-PCR was 
performed on 100 ng of ligated DNA using the primers TnAB1(5’- 
CATAATGAAATAAGATCACTACCGGGC-3’) and TnAB2 (5’-
GTGGTCGAACGTTGTCATAGGGA-3’), which face outward from the transposon sequence. The 
Inverse-PCR products were purified using the QIAEX II Gel Extraction Kit (QIAGEN, Valencia, 
CA) and sequenced using the primers of TnAB1 and TnAB2. The resultant sequences were aligned 
with the complete genome of P. aeruginosa PAO1 (Stover et al., 2000) or E. coli K-12 (Blattner et 
al., 1997) to confirm the insertion site of transposon.  
 
 
Figure 6-1-1. Structure of rhamnolipid biosynthetic gene RhlAB-containing Transposon (TnRABa 
or TnRABb); Cm:chloramphenicol resistant cassette; P: RhlAB native promoter or T7 promoter; 
TnRABa with the native promoter of RhlAB; TnRABb with T7 promoter fused with RhlAB. 
 
 
Figure 6-1-2. Transposome TnRABasome or TnRABbsome construction 
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Figure 6-1-3. Transposome electroporation and mutant selection. 
 
Rhamnolipid quantification 
Rhamnolipid was quantified in triplicate by the colorimetric determination of sugars with orcinol 
(Candrasekaran and Bemiller 1980).  Rhamnolipid was purified by first separating the cells from 
supernatant by centrifugation (10,000×g).  The supernatant was then extracted with chloroform and 
ethanol. The 0.5 mL rhamnolipid sample was extracted with 1 mL chloroform:ethanol (2:1, v/v).  
The organic phase was evaporated to dryness and 0.5 mL of H2O was added.  To 0.1 mL of each 
sample with suitable dilution, 0.9 mL of a solution containing 0.19% orcinol (in 53% H2SO4) was 
added.  After heating for 30 min at 80ºC the samples were cooled at room temperature and the 
OD421 was measured.  The rhamnolipid concentration was calculated from standard curves prepared 
with L-rhamnose (0-50 mg/L) and expressed as rhamnose equivalent. 
 
Rhamnolipid purification, TLC and HPLC/MS analysis 
The rhamnolipid was precipitated by acidifying culture supernatant to pH 2 with concentrated HCl 
and kept at 4°C overnight, then recovered by centrifugation at 10,000×g for 1 h and dissolved in 
deionized water.  2 volumes of chloroform:ethanol (2:1, v/v) were added to rhamnolipid solution 
and shaken 30 min for extraction.  The organic phase was picked and evaporated to dryness. Finally 
the rhamnolipid residue was dissolved in deionized water to 500 mg/L.   
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The purified rhamnolipid was separated, visualized, and compared with known rhamnolipid 
sample (JBR425, Jeneil Biosurfactant Co., LLC) using TLC (silica gel 60 plate).  A 10 μL sample 
(500 mg/L) was loaded into a silica gel 60 plate.  After drying at room temperature, the silica gel 
was developed with a solution of chloroform-methanol-water (65:15:2 by volume), then visualized 
using a 50:1:0.05 (by volume) mixture of the solution glacial acetic acid-sulfuric acid-anisaldehyde 
at 90°C for 30 min.  The HPLC/MS analyses were performed according to Schenk’s method with 
minor modification (Schenk et al., 1995).  Briefly, a Gemini C18 column (2×50 mm, 5μm particle) 
from Phenomenex and a ThermoFinnigan LCQ Classic ion trap mass spectrometer were used.  The 
HPLC gradient was: starting at 8% solvent B and holding for 1 minute, then ramping to 75% 
solvent B in 20 minutes, holding at 75% solvent B for 10 minutes, backing to 8% solvent B in 1 
minute and holding at 8% solvent B for 5 minutes. Solvent A is 98:2 (v/v) water:acetonitrile with 
0.1% acetic acid, and solvent B is 10:90 water:acetonitrile with 0.1% acetic acid.  A 10μL sample 
of 50 mg/L rhamnolipid was applied for HPLC/MS analysis. The mass spectrometer was operated 
in the negative ion mode scanning 250-950 m/z range.  
IFT characteristics of rhamnolipid 
The IFT was determined by using a spinning drop tensiometer (Temco Inc.) as detailed by Cayais 
(1975).   Aqueous rhamnolipid solution was loaded into glass tube (5×100 mm), followed by 
injection of 1.5 μL n-octane.  The glass tube with solution was spun in the tensiometer, and IFT was 
determined from the n-octane drop geometry.  After spinning for 10 min, the data were collected for 
analysis.  In these studies, we measured the “fresh” IFT values without pre-mixing rhamnolipid 
solution and n-octane together to reach phase equilibrium.  To adjust the pH of rhamnolipid 
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solution, Citrate-Na2HPO4 buffer (pH 3-8) and Boric acid-KCl-NaOH buffer (pH 8-10) were used.  
Unless noted otherwise, IFT was measured at 30°C. 
 
Sand pack core flooding test 
A sand-pack core flooding test was performed at room temperature according to Shuler’s method 
with some modifications (Shuler et al., 1989).  Dried sand (28-60 mesh) manufactured by Paragon 
Building Products Inc (Norco, CA) was packed into a stainless steel tube (2×60cm) to create an 
artificial core.  This sand pack was placed horizontally and the air evacuated from it with a vacuum 
pump.  Next, a buffer-brine solution (Citrate- Na2HPO4 buffer, with 2 wt% NaCl added) adjusted to 
pH 5.0 was introduced at 1 mL/min into the pack so that this aqueous phase now occupies all of the 
pore space.  This particular buffer-brine combination was selected because, based on the IFT 
measurements, rhamnolipid had lowest IFT under this condition.  The pore volume (PV) of this 
pack was calculated as the volume of brine that is imbibed (calculated by weighing the sand-packed 
core before and after being saturated with this brine of known density.)  The porosity of the sand 
pack is the pore volume divided by its total volume.  The brine permeability of the pack is 
calculated from Darcy’s Law by injecting the buffer-brine at a constant flow rate and measuring the 
pressure gradient. For the sand pack experiment reported here, the pore volume, porosity, and 
permeability is 85 ml, 45%, and 17.8 Darcies, respectively. Next, n-octane (selected to be the oil 
phase) displaced the brine in the sand pack until no more water came out .  The oil-saturated core 
was aged for 24 h.  Then the buffer-brine was injected into the aged oil-saturated core until no more 
oil came out.  
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So at this point, the sand pack core with trapped oil was ready for flooding with rhamnolipid 
solution.  About 3 PV of 250 mg/L rhamnolipid solution (made up in Citrate- Na2HPO4 buffer, 2% 
NaCl, pH 5.0) were injected at 1mL/min.  This same flow rate is used in all the flow steps 
associated with the sand pack experiment.    Next, the core was shut in and incubated overnight at 
room temperature. The other 3 PV of 250 mg/L rhamnolipid solution was injected at 1mL/min 
during the second day. After concluding rhamnolipid flooding, 6 PV of buffer-brine were injected. 
The produced fraction was collected in a titration tube with 0.1mL accuracy. After keeping few 
minutes, the oil phase and water phase would separate naturally, and the oil volume was measured 
according the graduation in the titration tube with 0.1 mL accuracy.  The oil recovery and water cut 
(percentage of oil- and non-oil phase in each elution fraction of approximately 10 mL were 
recorded during the rhamnolipid solution and subsequent buffer-brine injection steps, as well as the 
cumulative oil recovery as a percent of the trapped oil before rhamnolipid flooding.  The IFT and 
the rhamnolipid concentration for some of the eluted fractions during the rhamnolipid and the 
buffer-brine flush were measured with the methods mentioned above.  
 
7.  RESULTS AND DISCUSSION  
 
7.1 Summary of the Tasks Performed 
Task 1.0  Directed evolution studies for P. aeruginosa  (24 months) 
These studies have identified several “super-mutants” with one or more desirable 
characteristics, 1) “super-activity”, 2) thermal stability, or 3) use of cheap substrates.  We have    
written a paper documenting in particular the detailed laboratory procedures to arrive at the  
successful mutant candidates.    
Subtask 1.1  (8 months)  --  Develop screening methods to carry out an evaluation of the  
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performance of candidate mutants, based on one of three approaches:  thin-layer chromatography, 
bioactivity assay or colormetric analysis.  Conduct the first round mutagenesis tests via Error-prone 
PCR.  Perform “base-case” fermentation with the natural, wild form of the two study bacteria.       
Subtask 1.2   (14 months)  --  Second round mutation studies to obtain to a smaller number of better 
candidate mutants.  Perform batch fermentation on selected mutated strains to demonstrate achieve 
a desired effect.  
Subtask 1.3  (12 months)  --  Further generation of improved mutations.  Perform batch 
fermentation on selected mutated strains to quantify changes in bio-surfactant production. 
 
Task 2.0  Genetic cloning of “supermutants” into thermophilic oilfield and other host bacteria 
strains (29 months) 
The purpose of these studies is to clone the mutants with high activity and thermal stability into 
microbes adaptable to in-situ, oilfield reservoir conditions.  Part of this task is to document the 
detailed laboratory procedures and results in our efforts to create a robust MEOR microbe.      
Subtask 2.1  (6 months)  --  Literature review of thermophilic microbes that are candidates for oil 
reservoirs.   
Subtask 2.2   (14 months)  --  Develop laboratory methods to add bio-surfactant function to these 
target microbes.  Initially use wild, natural versions of P. aeruginosa  as the genome source. 
Subtask 2.3   (9 months)  --  Clone the mutant with the best features for in-situ MEOR (high activity 
and thermal stability) into the E.Coli cells.  
Task 3.0  Evaluation of Bio-Surfactants and Bio-Systems for EOR  (21 months) 
The purpose of these studies is to 1) characterize and optimize the target bio-surfactants 
(rhamnolipids and surfactin) as candidate chemicals for conventional chemical EOR. One activity 
documents the surfactant performance screening procedures and results in a report.     
Subtask 3.1  (5 months)  --  Micro-scale tests with purified rhamnolipid.  Develop analytical 
methods to measure bio-surfactant concentrations in solution.  Using whole cell lysate generated 
from the wild bacteria strains, determine phase behavior and IFT versus a series of n-alkanes to 
characterize the behavior of the 2 bio-surfactants as EOR agents.  Also conduct screening tests for 
bio-surfactant adsorption onto reservoir materials such as kaolinite. 
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Subtask 3.2   (9 months)  -- Use whole cell lysate from fermentation tests from the best 
“supermutants” to spot check the bio-surfactant phase behavior and IFT versus a series of n-
alkanes, plus re-test the solid adsorption behavior (expect same results as in Subtask 3.1).  Conduct 
detailed tertiary oil displacement performance tests of generated rhamnolipid and surfactin in Berea 
(and perhaps also in carbonate) core floods.  Optimize oil-displacement performance for at least one 
of the two candidate bio-surfactant systems for an example light crude oil system.  Compare and 
contrast with a synthetic alkyl aryl sulfonate surfactant system.     
Subtask 3.3   (7 months)  --  Conduct laboratory core flood tests of genetically engineered versus 
wild strain microorganisms for MEOR.  Evaluate in a series coreflood experiments the ability of 
test bio-systems to displace waterflood residual oil.  
 
7.2 Directed evolution studies for P. aeruginosa and cloning of mutants into host bacteria 
strains 
 
7.2.1 Overview the molecular mechanism of the rhamnolipid bio-synthesis 
 
The goal of the studies in this Task is to identify the “super-mutant-genes” involved in the 
rhamnolipid or surfactin biosynthesis with one or more desirable characteristics, 1) “super-activity”, 
2) thermal stability, or 3) use of cheap substrates.   
 P. aeruginosa produces extracellular glycolipids named rhamnolipid which is composed of 
L-rhamnose and 3-hydroxyalkanoic acid. In liquid cultures, they are produced as a complex mixture 
of congeners containing one or two 3-hydroxy fatty acids of various lengths, linked to a mono- or 
dirhamnose moiety. In general, the two more abundant rhamnolipids are L-rhamnosyl-3-
hydroxydecanoyl-3-hydroxydecanoate and L-rhamnosyl-L-rhamnosyl-3-hydroxydecanoyl-3-
hydroxydecanoate. According to the biosynthetic pathway proposed by Burger et al, rhamnolipid 
synthesis proceeds by two sequential glycosyl transfer reactions, each catalyzed by a different 
rhamnosyltransferase. The first rhamnosyltransferase, which catalyses the transfer of TDP-L-
rhamnose to 3-(3-hydroxyalkanoyloxy) alkanoic acid (HAA), is encoded by the rhlAB operon 
(Figure 7-2-1). Both genes, co-expressed from the same promoter, are essential for rhamnolipid 
synthesis. Environmental factors, especially nutritional conditions, influence rhamnolipid 
production. This quorum sensing system is composed of rhlI, the N-butyrylhomoserine lactone 
autoinducer synthase gene, and rhlR, which encodes the transcriptional activator. The second 
rhamnosyltransferase, encoded by rhlC, has been characterized and its expression shown to be co-
coordinately regulated with rhlAB by the same quorum sensing system. 
 
 
 
Figure 7-2-1.  Putative synthetic pathway of rhamnolipids in P. aeruginosa 
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7.2.2 Vector preparation for gene cloning 
 
1) The following commercial vectors were used in our rhamnosyltransferase gene cloning study. 
a) pUC19  
pUC19 (Invitrogen) is a small, high-copy number E. coli plasmid cloning vector containing 
multiple cloning site and Ampicillin resistance gene (Figure 7-2-2a). 
 
b) pACYC177 
pACYC177 (New England Biolabs) is an E. coli plasmid cloning vector containing double drug 
resistance gene (amicillin and kanamycin).( Figure 7-2-2b). 
 
c) pACYC184 
pACYC184 (New England Biolabs) is an E. coli plasmid cloning vector containing double drug 
resistance gene (chloramphenicol and tetracycline).( Figure 7-2-2c). 
 
d) pBluescript SK(+) II 
pBluescript SK(+) (Stratagene) II is a small, high-copy number E. coli phagemid cloning vector 
containing multiple cloning site and ampicillin resistance gene (Figure 7-2-2d). 
 
e) pET30a(+) 
pET30a(+) (Novagen) is an E. coli plasmid expression vector containing multiple cloning site and 
kanamycin resistance gene (Figure 7-2-2e). 
f) pMOD-2 Transposon Construction Vector 
pMOD-2 Transposon Construction Vector (Takara) is a pUC-based vector containing multiple 
cloning site and ampicillin resistance gene (Figure 7-2-2f). After PvuII or PshAI digestion, a Tn5 
transposon was produced. 
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                                           (e)                                                                          (f) 
Figure 7-2-2.  Maps of commercial vectors used in our gene-cloning study 
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2) Vectors specially constructed for our rhamnosyltransferase gene cloning study 
a) pUC19C 
pUC19 was digested with AatII and AdhI and then treated with T4 DNA polymerase to produce a 
1.7kb double blunted-end fragment (Figure 7-2-2a). pACYC184 was digested BsaAI and Bme1580I 
and then treated with T4 DNA polymerase to produce a 750bp double blunted-end fragment which 
contains chloramphenicol resistance cassette (Figure 7-2-2c). These two fragments were ligated 
with T4 DNA ligase and transformed into E. coli to produce recombinant plasmid pUC19C (Figure 
7-2-3a). 
 
b) pUC19K 
pUC19 was digested with AatII and AdhI and then treated with T4 DNA polymerase to produce a 
1.7kb double blunted-end fragment (Figure 7-2-2a). pACYC177 was digested DraIII and HaeII and 
then treated with T4 DNA polymerase to produce a 1.2kp double blunted-end fragment which 
contains kanamycin resistance cassette (Figure 7-2-2b). These two fragments were ligated with T4 
DNA ligase and transformed into E. coli to produce recombinant plasmid pUC19K (Figure 7-2-3b). 
 
c) pMOD-2C 
pMOD-2 Transposon Construction Vector was digested with SmaI and then treated with alkaline 
phosphatase to produce linear fragment. pACYC184 was digested BsaAI and Bme1580I and then 
treated with T4 DNA polymerase to produce a 750bp double blunted-end fragment which contains 
chloramphenicol resistance cassette (Figure 7-2-2c). These two fragments were ligated with T4 
DNA ligase and transformed into E. coli to produce recombinant plasmid pMOD-2C (Figure 7-2-
3c). Thus, the recombinant plasmid pMOD-2C can produce Tn5-derived tranposon which 
containing chloramphenicol resistance gene after PvuII or PshAI digestion. 
 
 
 
 
Apa LI (178) Apa LI (178)
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Figure 7-2-3. Vectors specially constructed in the gene-cloning study 
 
7.2.3 Cloning Genes Involved in Rhamnolipid Biosynthesis 
 
1)  Cloning and Identification of Rhamnolipid Biosynthesis Gene Cluster from Pesudomonas 
aeruginosa PAO1  
Gene Cloning by PCR 
a) PCR product of RhlABRI was digested with XbaI and HindIII and cloned into pUC19 and 
pBluescript II SK(+), respectively. The recombinant plasmid pUCR01 and pSKR01 were 
produced, respectively (Figure 7-2-4a and Figure 7-2-4b). 
b) PCR product of RhlAB was digested with XbaI and EcoRI and cloned into pUC19 and 
pBluescript II SK(+), respectively. The recombinant plasmid pUCRPAB and pSKRPAB 
were produced, respectively (Figure 7-2-4c and Figure 7-2-4d). 
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BamHI (1170)
ClaI (338)
Hin dIII (1200)
Nco I (1001)
Pst I (1192)
Xba I (1176)
Eco RI (375)
Eco RI (700)
 Apa LI (1754)
  Eco RI (397)
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                              (c)                                                                                (d) 
Figure 7-2-4. Recombinant plasmids containing rhamnolipid biosynthesis genes 
 
7.2.4  Cloning and Identification of dTDP-L-rhamnose Biosynthetic Gene Cluster from 
Pesudomonas aeruginosa PAO1 
 
Whole dTDP-L-rhamnose Biosynthetic Gene Cluster RmlABCD with native operon promoter 
(containing upstream 300bp sequence) was amplified with primer PaRml-1 and PaRml-2 and P. 
aeruginosa PA01genomic DNA (from ATCC) as template; PCR product of RmlABCD was 
digested with XbaI and HindIII and cloned into pUC19C. The recombinant plasmid pUCCPaRml 
was produced and identified by restriction digestion analysis (Figure 7-2-5). 
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SmaI (2459)
SmaI (3114)
Nco I (2564)
Nco I (2906)
Nco I (3340)
Nco I (4491)
ClaI (2258)
BamHI (1998)
Nco I (2058)
BamHI (3967)
BamHI (4527)
SmaI (2288)
Sma I (2943)
SmaI (4525)
Nco I (2492)
PstI (2743)
PstI (3880) Nco I (2834)
Pst I (2857)
Nco I (3458)  
pSKRPAB
5542 bp
RhlB
RhlA
ClaI (685)
Eco RI (702)
HindIII (690)
Xba I (3313)
pUCRPAB
5270 bp RhlB
RhlA
Eco RI (397)
HindIII (3032)
Xba I (3008)
Nco I (526)
Nco I (831)PstI (777)
BamHI (2306)BamHI (2866)
Sma I (1282)
Sma I (2864)
Nco I (1173)
Nco I (1797)
Pst I (1082)
Pst I (1196)
Pst I (2219)
BamHI (2001)
BamHI (2561)
Sma I (977)
Sma I (2559)
Nco I (868)
PstI (891)
Nco I (1492)
PstI (1914)
PstI (3024)
Eco RI (397)
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pUCCPaRml
6310 bp
RmlB
RmlD
RmlA
RmlC
HindIII (4221)
Nco I (6080)
Xba I (424)
BamHI (418)
BamHI (1771)
Sma I (415)
Eco RI (5779)
Sma I (448)
ClaI (636)
ClaI (1607)
PstI (1816)
PstI (4025)
PstI (2356)
Sma I (3598)
 
 
Figure 7-2-5. Recombinant plasmids containing dTDP-L-rhamnose Biosynthetic Gene Cluster 
 
7.2.5  Cloning and Identification of polyhydroxyalcanoate synthase PhaC and ketoacyl reductase 
RhlG from Pesudomonas aeruginosa PAO1  
a)  Polyhydroxyalcanoate synthase PhaC with native operon promoter (containing upstream 300bp 
sequence) was amplified with primer PaPhaC-1 and PaPhaC-2 and P. aeruginosa PA01genomic 
DNA (from ATCC) as template; PCR product of PhaC was digested with KpnI and XbaI and cloned 
into pUC19K. The recombinant plasmid pUCKPaPhaC was produced and identified by restriction 
digestion analysis (Figure 7-2-6a). 
 
b)  Ketoacyl reductase RhlG with native operon promoter (containing upstream 300bp sequence) 
was amplified with primer PaRhlG-1 and PaRhlG-2 and P. aeruginosa PA01genomic DNA (from 
ATCC) as template; PCR product of RhlG was digested with XbaI and SalI and cloned into 
pUC19K. The recombinant plasmid pUCKPaRhlG was produced and identified by restriction 
digestion analysis (Figure 7-2-6b). 
 
c)  PCR product of RhlG after XbaI and SalI digestion was also cloned into pUCKPaPhaC. The 
recombinant plasmid pUCKPaPhaCRhlG was produced and identified by restriction digestion 
analysis (Figure 7-2-6c). 
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                           (a)                                                                        (b) 
 
 
 
 
 
 
 
 
                                                                               (c)    
Figure 7-2-6. Recombinant plasmids containing Polyhydroxyalcanoate synthase and Ketoacyl 
reductase 
 
7.2.6  Construction of Engineered E. coli for producing rhamnolipids 
 
The different combinations of plasmids that contain rhamnolipid biosynthetic genes were 
transformed into E. coli DH5α to obtain the following engineered strains as listed in Table 1. 
 
pUCKRhlG
3942 bp RhlG
ClaI (2902)
Eco RI (397)
PstI (1421)
Kpn I (413)
Sal I (1411)
Xba I (424)
pUCKPhaC
4971 bp
PhaC
Eco RI (397)
BamHI (903)ClaI (3931)
Kpn I (413)
Sal I (2440)
Xba I (2434)
Hin dIII (4358)
Sma I (566)
BamHI (418)
Sma I (415)
Sma I (4114) Eco RI (577)
Hin dIII (3329)
Pst I (947)
BamHI (440)
Sma I (3085)Pst I (1409)
Pst I (1592) Nco I (1074)
Sma I (1937)
HindIII (1429)
Pst I (2246)
Nco I (1266)
Sma I (2321)
Sma I (2358)
Pst I (2450)
Hin dIII (2458)
Eco RI (397)
pUCKPhaCRhlG
5952 bp PhaC
RhlG
ClaI (4912)
Kpn I (413)
Sal I (3421)
Xba I (2434)
HindIII (5339) Sma I (566)
Sma I (5095) Eco RI (577)
BamHI (903)
PstI (947)
PstI (1409)
PstI (1592)
Sma I (1937)
HindIII (3439) PstI (2246)
BamHI (2450)Nco I (3084)
PstI (3431) Sma I (2321)
Sma I (2358)
Nco I (3276)
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Table 1 Engineered E. coli for producing rhamnolipids 
Strain Phenotype 
E. coli ABMSR01 containing pSKR01; Amp 
E. coli ABMUR01 containing pUCR01; Amp 
E. coli ABMSRAB  containing pSKRAB; Amp 
E. coli ABMURAB containing pUCRAB; Amp 
E. coli ABMR71 containing pUCRAB and pUCCRml; Amp, Cm 
E. coli ABMR701 containing pUCRAB, pUCCRml and pUCKPhaC; Amp, Cm, 
and Kan 
E. coli ABMR702 containing pUCRAB, pUCCRml and pUCKRhlG; Amp, Cm, 
and Kan 
E. coli ABMR703 containing pUCRAB, pUCCRml and pUCKPhaCRhlG; Amp, 
Cm, and Kan 
Amp: ampicillin resistance; Cm: Chloramphenicol resistance; Kan: kanamycin resistance. 
 
7.2.7  Construction of RhlAB-containing Transposon insertion mutants  
 
Rhamnosyltransferase 1 complex RhlAB with native operon promoter (containing upstream 400bp 
sequence) was amplified with primer RhlABRL-1(5’- 
CCCAATCTCTAGATGCCTTTTCCGCCAACCCCTCGCTG-3’) and RhlB-2 (5' - AAC CAA 
GCT TTC AGG ACG CAG CCT TCA GCC ATC G - 3') and P. aeruginosa PA01genomic DNA as 
template; PCR product of RhlAB was digested with XbaI and HindIII and cloned into pMOD-2C to 
produce the recombinant plasmid pMOD-2CRAB (Figure 7-2-7). 3.5kb RhlAB-containing 
Transposon was produced by digesting pMOD-2CRAB with PshAI. RhlAB-containing Transposon 
(TnCRPAB) was transformed into transposome after adding transposase (Figure 7-2-8).  
 pMOD-2CRPAB
5908 bp
CmR
RhlA
RhlB
PshAI (309)
Eco RI (375) Eco RI (700)
 
HindIII (3789)
Xba I (1176)
Nco I (1001)
 PshAI (3853)
Sma I (1629)
Nco I (3658) Xho I (3645)
Pst I (3415)
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Figure 7-2-7 Recombinant plasmids with RhlAB-containing Transposon 
 
 
 
 
 
 
 
 
                                                                          (a) 
 
 
(b) 
 
Figure 7-2-8 Structure of RhlAB-containing Transposon (a) and diagram of transposome 
construction (b) 
 
Sma I (3211)
Xho I (2359)
Pst I (2278)
Pst I (3301)
Nco I (3316)
Nco I (2692)
 
TnC RPAB
3544 bp
RhlA
RhlB
CmR
T n5T n5
ClaI (30) HindIII (3481)
XbaI (868)
SmaI (1321)
BamHI (1315)
SmaI (2903)
EcoRI (67)
EcoRI (392)
XhoI (2051)
XhoI (3337)
BamHI (862) PstI (2993)
BamHI (1875)
PstI (1970)
PstI (3107)
NcoI (693) NcoI (3008)
NcoI (3350)
NcoI (2384)
 
RhlAB-containing Transposome then was transformed into P. aeroginosa PAO1RhlA- (a gift from 
Dr. Joseph S. Lam) and P. fluorescens ATCC15453 by electroporation. Insertion mutants was 
selected by antibiotics resistance and confirmed by PCR (Figure 7-2-9).  
 
Figure 7-2-9 Diagram of Insertion mutant construction and selection 
 
7.2.8 Error-prone PCR of Rhamnosyltransferase complex RhlAB 
 
Error-prone PCR of Rhamnosyltransferase 1 complex RhlAB was conducted with GeneMorph II 
Random Mutagenesis Kit (Stratagene) according to instruction manual. The primers for PCR were 
RhlABRL-1 (5’- CCCAATCTCTAGATGCCTTTTCCGCCAACCCCTCGCTG-3’) and RhlB-2 (5' 
- AAC CAA GCT TTC AGG ACG CAG CCT TCA GCC ATC G - 3'). Plamid pUCRPAB (Figure 
7-2-2-1c) was as DNA template. 
 
7.2.9 Library construction of RhlAB-containing Transposon insertion mutants of P. aeroginosa 
 
Error-prone PCR product of RhlAB was ligated with 3.3kb XbaI-HindIII fragment from plasmid 
pMOD-2C (Figure 7-2-2c) with T4 DNA liagse. Ligation product was digested with PshAI and a 
3.5kb PshAI-fragment which is RhlAB-containing transposon was purified from digestion product. 
RhlAB-containing transposon was transformed into P. aeroginosa PAO1-RhlA- by electroporation. 
Electroporated P. aeroginosa PAO1-RhlA- was plated in LB plus chloramphenicol (50μg/L) and 
incubated at 30ºC for 3 days. Those colonies appeared on LB agar generally were RhlAB-
containing Transposon insertion mutants. We finally construct a library of 3500 mutants for further 
screening for rhamnolipid production and structure analysis by HPLC-MS. 
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7.2.10 Develop screening methods to carry out an evaluation of the performance of candidate 
mutants 
 
Analytical method for rhamnolipid (Oricinol Method) 
1) Rhamnolipids were purified by first separating the cells from supernatant by centrifugation 
(10000 ×g);  
2) The supernatant was then extracted with chloroform and ethanol. 0.5mL rhamnolipid sample 
was extracted with 1mL chloroform:ethanol (2:1, v/v); 
3) The organic phase was evaporated to dryness and 0.2mL of H2O was added;  
4) To 0.1mL of each sample 0.9mL of a solution containing 0.19% orcinol (in 53% H2SO4) was 
added;  
5) After heating for 30min at 80ºC the samples were cooled at room temperature (15-20min) and 
the OD421 was measured;  
6) The rhamnolipid concentrations were calculated from standard curves prepared with L-
rhamnose (0-50mg/L) and expressed as rhamnose equivalents. 
Results 
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Figure 7-2-10. Standard Curve of L-Rhamnose assay by Orcinol method 
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semi-quantitative agar plate assay to detect the extracellular rhamnolipids. 
 
On the light blue agar that contains CTAB and basic dye methylene blue, rhamnolipid- productive 
pseudomonas colonies are surrounded by dark blue halos. And the diameter of the dark blue halo is 
proportional to the rhamnolipid concentration. The Figure 7-2-11 illustrates the blue colonies that 
produce rhamnolipids. 
 
Figure 7-2-11. Rhamnolipids form blue halo on agar that contains CTAB and basic dye methylene blue 
 
Quantification of biosurfactant by Oil Spreading Technique  
 
1) Add 50mL of distilled water to a large Petri dish (15cm diameter); 
2) Add 50μL of petroleum crude oil (CRC53352-1, McElroy field, Chevron Texaco) to the surface 
of the water; 
3) Add 10μL (for different biosurfactant, there is different concentration range) to the surface of 
oil; 
4) Measure the diameter of the clear zone on the oil surface after 2 minutes; 
5) Make plot of standard curve. The diameters of triplicate samples were determined (Figure 7-2-
12).  
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The relationship between the diameter of the clear zone obtained
by the oil spreading technique and the surfactin
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The relationship between the diameter of the clear zone
obtained by the oil spreading technique and the rhamnolipid
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Figure 7-2-12. The relationship between the diameter of the clear zone obtained by the oil spreading 
technique and the concentration of biosurfactant. Error bars indicate the standard deviation of the 
three independent measurements. Surfactin was from Sigma (St. Louis, MO). Rhamnolipid was 
from bench-top fermentation by Pseudonomas fluroscrens PFAB01 and the concentration was 
quantified by Orcinol method. 
 
7.3 Production and characterization of rhamnolipid  
 
7.3.1 Rhamnolipids production and characterization by engineered P. aeruginosa and E. coli 
 
RhlAB is the key enzyme of rhamnolipids biosynthesis, but this biosynthesis was modulated by the 
complex transcriptional regulatory network in P. aeruginosa (Soberon-Chavez and Aguirre-
Ramirez, 2005). However, to achieve the rhamnolipids production in the strains which can not 
38 
 
39 
 
produce rhamnolipids, integrating RhlAB is indispensable. In this circumstance, convenient 
molecular biotechniques would give great insights.  Here, we show the state-of-the-art transposome-
mediated chromosomal integration (Figure 7-2-8) to modify metabolic pathway of rhamnolipid 
biosynthesis. Briefly, RhlAB with native promoter and selection maker gene Cm (chloramphenicol 
resistance gene) were cloned into Tn5 derived transposon plamid pMOD-2 (Epcentre 
Biotechnologies, Madison, WI) to produce the recombinant plasmid pMOD-2CRAB. pMOD-
2CRAB was digested with PshAI to obtain chimeric transposon TnRAB (Figure 7-2-7) which can 
bind transposase to produce transposome TnRABsome. TnRABsome was electroporated into P. 
aeruginosa PAO1-rhlA- wild-type strain. Consequently, we successfully constructed rhamnolipid-
producing P. aeruginosa from wild-type strain (which was absent the ability for rhamnolipid 
biosynthesis) by transposome-mediated chromosomal integration of RhlAB after genotypic and 
phenotypic analysis. RhlAB with native promoter was inserted into chromosome of rhamnolipid-
deficient strain (P. areuginosa PAO1-rhlA-), and mutants strain P. areuginosa PEER02 which was 
confirmed to have RhlAB by PCR amplification and subsequent sequencing (data not shown) can 
effectively produce rhamnolipid in saline media with either glucose, or soybean oil as substrate.  As 
showed in Table 2, soybean oil was better substrate for rhamnolipid production than glucose, and 
the yield of rhamnolipid in soybean oil was two-fold more than in glucose. 
 
Table 2 Rhamnolipid fermentation by Pseudonomas aeruginosa mutant 
 
Stains Rhamnolipid (mg/L) 
Glucose Soybean oil 
P. areuginosa PAO1-RhlA- ND ND 
P. areuginosa PEER02 785.4 1819.1 
          ND: none detected  
 
In addition, to overcome the complex environmental regulation of rhamnolipid biosynthesis 
in P. aeruginosa, we attempted to achieve rhamnolipd formation in E. coli by same transposome-
mediated chromosomal integration of RhlAB. T7 promoter replace native promoter of RhlAB in the 
transposon TnRAB to produce another chimeric transposon TnRAB7. This new transposon was 
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inserted into the chromosome of E. coli BL21(DE3) by transposome-mediated integration to 
engineer a strain E. coli TnERAB which was also confirmed by PCR (data not shown). With IPTG 
induction, E. coli TnERAB can produce rhamnolipid both in rich (LB) and minimal (MS) media 
and glucose as substrate. Because E. coli can grow better in LB media than minimal media, 
rhamnolipid yield is higher in LB media (Table 3).  
 
Table 3 Rhamnolipid fermentation by engineered E. coli in rich or minimal media 
 
Stains Rhamnolipid (mg/L) 
LB plus 0.4% glucose MS plus 0.4% glucose 
E. coli BL21(DE3) ND ND 
E. coli TnERAB 175.3 75.6 
            ND: none detected  
 
Rhamnolipids, as the best known biosurfactants, consist of one or two units of rhamnose 
linked to one or two fatty acid chains with C8-C12 carbon atoms, which may or may not be 
saturated (Figure 7-3-1). TLC results suggested that the isolated surface-active products from P. 
aeruginosa PAAB and E. coli TnERAB were composed of rhamnolipids (Figure 7-3-1). The 
products were separated on TLC plates alongside a sample of a commercially available purified 
rhamnolipid (JBR425, Jeneil Biosurfactant Company). When these samples were visualized, the 
products from P. aeruginosa PEER02 have two spots which were similar to the commercial 
product. The lower spot consisted of di-rhamnolipids, while the higher spot consisted of mono-
rhamnolipids. The products from E. coli TnERAB only have the higher spots which are mono-
rhamnolipids. Thus, we also proved that RhlAB only synthezied mono-rhamnolipids. Di-
rhamnolipids biosynthesis needs help from other gene(s).  P. aeruginosa PEER02 can produce di-
rhamnolipids because it contain gene RhlC which was confirmed by PCR and sequencing (data not 
shown). 
                                     (a)            (b)            (c)                            (d)           (e) 
Figure 7-3-1 TLC analysis of rhamnolipids from engineered strains. (a) Commercial rhamnolipids 
JBR425; (b) Rhamnolipids produced by P. aeruginosa PEER02 with soybean oil as glucose; (c) 
Rhamnolipids produced by P. aeruginosa PEER02 with soybean oil as substrate; (d) Rhamnolipids 
produced by E. coli TnERAB in LB plus glucose media; (e) Rhamnolipids produced by E. coli 
TnERAB in MS plus glucose media; (10 μL sample of 500mg/L for each lane). 
 
Then, the products from our engineered strains were next submitted to HPLC/MS analysis 
to further confirm the presence of rhmanolipids.  Rhamnolipids in crude fermentative broth was 
precipitated after acidifying with concentrated HCl, and extracted with chloroform : ethanol 
(2:1,v/v). Organic phase was collected and air dried. After drying, the yellow oil paste was 
suspended in water. The sample was ready for LC-MS analysis as well as for IFT analysis. 
Rhamnolipid structural information was obtained through the use of mass detector equipment with 
electrospray ionization (ESI) probe. Figure 7-3-2 presents the base peak ion intensity 
chromatograms for the rhamnolipid samples produced by our engineered strains with soybean oil or 
glucose as carbon source. The profiles of these chromatograms differ mostly in the late eluting 
region which is composed mainly of rhamnolipids containing only one fatty acid moiety. The 
proportions of the various rhamnolipids listed in Table 4 were obtained from the relative intensities 
of their corresponding pseudomolecular ions. For rhamnolipids of the same molecular weight which 
were chromatographically resolved, this was simply performed by integration of the intensities of 
their pseudomolecular ion. For isomers that were not chromatographically resolved, their relative 
proportion was determined by the relative intensities of different fragments ions produced by 
cleavage of the two molecules at the same position. For example, the rhamnolipid Rha-C8-C10 was 
not sufficiently separated from Rha-C10-C8 to allow direct quantification on the basis of the 
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intensity of their pseudomolecular ion at m/z 475. However, their mass spectra differ by the 
presence of an m/z 305 ion for the former and an m/z ion 333 for the latter. These two ions arise 
from cleavage at the 3-carbon-oxygen bond in both molecules. The relative intensities of the two 
isomers were calculated by measuring the relative intensities of both ions, in an averaged spectrum 
obtained from all the spectra presenting the proper pseudomolecular ion, and multiplying these two 
values with the intensity of their common pseudomolecular. This method allows the analysis of 
very closely related rhamnolipids without resorting to long and difficult chromatographic 
separation.  
 
 
(a) 
 
(b) 
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 (c) 
 
(d) 
Figure 7-3-2. Base peak ion intensity chromatograms of rhamnolipids from various sources. (a) 
rhamnolipids produced from minimal media supplemented soybean oil by P. aeruginosa PEER02; 
(b) rhamnolipids produced from minimal media supplemented glucose by P. aeruginosa PEER02; 
(c) commercial rhamnolipids JBR425; (d) rhamnolipids produced from minimal media 
supplemented glucose by E. coli TnERAB; 
 
In the ion intensity chromatograms (Figure 7-3-2), the main structural composition of 
rhamnolipids from each samples were labeled. For the samples from E. coli, the main composition 
is Rha-C10-C10 which almost occupied 40~60% of total amount according the samples from 
different media. The main compositions of the samples from engineered P. aeruginosa also have 
C10-C10 carbon chain: Rha-C10-C10 and Rha-Rha-C10-C10. The percentage of these 
compositions is more than 30%. Another abundant structure composition of rhamnolipids from P. 
aeruginosa is Rha-Rha-C10-C12 or Rha-Rha-C12-C10. They have same pseudomolecular ion and 
total amount is more than 10%. 
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 Table 4. Structure and relative abundance of the rhamnolipids from various sources 
 
JBR425: commercial rhamnolipids; PEER02/G: rhamnolipids from P. aeruginosa PEER02 with glucose as substrate in 
MS media; PEER02/S: rhamnolipids from P. aeruginosa PEER02 with soybean oil as substrate in MS media; 
TnERAB: rhamnolipids from E. coli TnERAB with glucose as substrate in MS media and IPTG induction; * ND: none 
detected  
 
7.3.2 Rhamnolipids production and characterization from various substrates by engineered 
Pseudomona aeruginosa 
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Rhamnolipids, as one of main type of biosurfactants, have advantages over their chemicals 
counterparts because they are biodegradable, have low toxicity, are effective at extreme 
temperatures or pH values (Cameotra and Makkar, 1998; Liang et al., 1999) and show better 
environmental compatibility (Georgiou et al., 1990). Nevertheless, from an economic standpoint, 
biosurfactants are not yet competitive with the synthetics. Rhamnolipids can only replace synthetic 
surfactants if the cost of the raw material and the process costs are reduced.  So far, several 
renewable substrates from various sources, especially from industrial wastes have been intensively 
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studied for microorganism cultivation and surfactant production at an experimental scale. Here we 
make efforts to use alternate low-cost substrates to facilitate industrial development of rhamnolipids 
production by engineered Pseudomonas aeruginosa which was constructed in our lab. 
 
 Fermentation experiments showed P. aeruginosa PEER02 can produce rhamnolipids in 
minimal salts media containing various carbon sources, including glucose, fructose, glycerol, 
ethanol, soybean oil, corn oil, frying oil, palm oil, peanut oil, coconut oil, olive oil, grape seed oil, 
etc. The results of preliminary carbon source test are shown below in Table 5. 
 
Table 5. Effect of various carbon sources on rhamnolipids production by P. aeruginosa PEER02 in 
minimal media 
 
Substrate 
 
 
                                              Fermentation time (day) 
                    2                                                4                                                 6 
Growth      RL (g/L)   Conversion    Growth        RL (g/L)      Conversion    Growth      RL (g/L)       Conversion 
Glucose    3.86      3.277             0.164     2.32         2.532     0.127        1.73             2.379         0.119 
Fructose    1.39      0.156             0.008     2.84         1.239     0.062        4.04             4.221         0.211 
Xylose    0.49      0.162             0.008     0.62         0.264     0.013        0.47              0.345         0.017 
Lactose    NG**      ND***          ND     NG         ND          ND        NG              ND         ND 
Sucrose    NG      ND              ND     NG         ND          ND        NG              ND         ND 
Maltose    NG      ND              ND     NG         ND          ND        NG              ND         ND 
Soluble starch    NG      ND              ND     NG         ND          ND        NG              ND         ND 
Ethanol    0.89      0.060              0.003     2.33         1.233     0.062        2.43              1.989         0.099 
Glycerol    3.89      2.472              0.124     4.73         9.969     0.498        4.97              7.296         0.365 
Soybean oil    4.88      5.049              0.252     4.09         7.095     0.355        1.70              3.648         0.182 
Corn oil    5.21      5.112              0.256     4.22         8.166     0.408        2.10              4.797         0.240 
Peanut oil    5.16      5.523              0.276     4.39         6.723     0.336        2.68              6.708         0.335 
Palm oil    5.71      4.233              0.212     2.49         4.362     0.218        2.37              4.071         0.204 
Coconut oil    5.71      6.099              0.305     3.82         5.448     0.272        2.23              6.363         0.318 
Grapeseed oil   5.51      5.166              0.258     1.85         4.152     0.208        0.94              4.863         0.243 
Olive oil   5.66      3.489              0.174     4.74         4.668     0.233        3.00              5.583         0.279 
Frying oil   5.49      4.881              0.244     4.00         7.347     0.367        2.05              4.230         0.212 
n-Octane   NG      ND              ND     NG         ND           ND        NG              ND         ND 
n-Decane   NG            ND  ND     NG         ND           ND        NG              ND         ND 
n-Dodecane   NG      ND              ND     NG         ND           ND        NG              ND         ND 
n-Tetradecane   NG      ND              ND     NG         ND            ND        NG              ND         ND 
n-Hexadecane   NG      ND              ND     NG         ND            ND        NG              ND         ND 
Crude oil   NG      ND              ND     NG         ND            ND        NG              ND         ND 
Mineral oil   NG      ND              ND     NG         ND            ND        NG              ND         ND 
* For liquid substrate, the conversion is g/mL, and for solid substrate, g/g; 
** NG: no growth; *** ND: none detected  
 
P. aeruginosa PEER02 can not grow in sucrose, lactose, maltose as well as all hydrocarbons 
tested. Thus, this engineered strain can not produce rhamnolipids with these substrates. Compared 
with the substrates of various plant oils, P. aeruginosa PEER02 produce less rhamnolipids with 
sugars as substrates. In all plants oils, corn oil is the best substrate for rhamnolipids production by 
P. aeruginosa PEER02. The yield is about 8g/L, and the productivity (conversion rate) is about 
34%. However, in our investigation, glycerol will give the highest yield and productivity. Its yield 
and productivity is about 10g/L and 50%, respectively. 
 
Rhamnolipids characterization from different substrates 
Rhamnolipids were produced with P. aeruginosa PEER02 from 12 different substrates, including 8 
plant oil, 2 sugars, two others, glycerol and ethanol. Rhamnolipids from different substrates were 
purified for HPLC/MS analysis (Figure 7-3-3). From base peak ion intensity chromatograms of 
rhamnolipids from various sources, the main compositions of each samples and their percentage 
were summarized in Table 3  The purified samples were also applied for interfacial tension analysis 
agains n-Octane (Table 4). Geneally, the higher the percentage of di-rhamnolipids with longer 
carbon chain was, the lower its IFT was. 
 
Rha-Rha-C10-C10 
Rha-C10-C10
Rha-Rha-C10-C12 
Rha-Rha-C12-C10
(a) Soybean oil 
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 Rha-Rha-C10-C10 
Rha-C10-C10
Rha-Rha-C10-C12 
Rha-Rha-C12-C10
(b) Corn oil 
 
 
Rha-C10-C10 
Rha-Rha-C10-C10
Rha-Rha-C10-C12 
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Rha-Rha-C10-C10 
Rha-Rha-C10-C12 
Rha-Rha-C12-C10
Rha-C10-C10
(h) Grapeseed oil 
 
 
Rha-Rha-C10-C10
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Rha-Rha-C12-C10
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Rha-Rha-C10-C10
Rha-C10-C10
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(k) Ethanol 
 
 
(l) Fructose 
Figure 7-3-3. Base peak ion intensity chromatograms of rhamnolipids produced from different 
carbon sources. (a) soybean oil; (b) corn oil; (c) frying oil; (d) palm oil; (e) coconut oil; (f) peanut 
oil; (g) olive oil; (h) grapeseed oil; (i) glucose; (j) glycerol; (k) ethanol; (l) fructose. The main 
compositions are labeled in each chromatogram. 
 
   Table 6. Structure and relative abundance of the rhamnolipids from various sources 
 
No.     
Substrate 
Rha-Rha-C10-C10 
m/z 649 
Rha-C10-C10 
m/z 503 
Rha-Rha-C10-C12 ( or C12-C10) 
m/z 677 
1 Soybean oil 37.4 47.7 14.9 
2 Corn oil 43.9 43.5 12.6 
3 Frying oil 36.8 48.8 14.4 
Rha-Rha-C10-C12 
Rha-Rha-C12-C10
Rha-C10-C10
Rha-Rha-C10-C10
Rha-Rha-C10-C12 
Rha-Rha-C12-C10
Rha-C10-C10
Rha-Rha-C10-C10 
50 
 
51 
 
4 Palm oil 51.3 31.3 17.4 
5 Coconut oil 47.7 33.6 12.4 
6 Peanut oil 49.6 32.6 17.8 
7 Olive oil 47.6 31.5 14.6 
8 Grapeseed oil 44.3 38.5 17.2 
9 Glucose 49.5 18.4 32.1 
10 Glycerol 52.5 22.2 34.6 
11 Ethanol 23.3 33.2 25.2 
12 Fructose 47.9 17.5 24.4 
 
7.3.2 Fed-batch fermentation of Rhamnolipids production by P. aeruginosa PEER02 
 
Fed-batch fermentations of rhamnolipids production with starting 2% (S2) and 4% (S4) soybean oil 
in fermentative media, respectively, were investigated. For S2, an additional 2% soybean oil was 
supplemented into media every day of first 4days. For S4, an additional 3% soybean oil was 
supplemented at second and fourth day, respectively. The final concentration of soybean oil was 
10% for both fed-batch fermentations. 
 
From Figure7-3-4, fed-batch fermentation greatly enhanced the production of rhamnolipids, 
and the yield reached 23~25g/L.  Generally speaking it is more efficient to add the substrate step 
wise, rather than all at the start of the fermentation process.  It could be expected that the surfactant 
production and percent conversion could be improved from this result when optimized as a 
commercial process. 
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Figure 7-3-4 Fed-batch fermentation of Rhamnolipids production by P.aeruginosa PEER02. Red 
line with solid square: rhamnolipids production curve of S2; Red line with unfilled square: 
rhamnolipids production curve of S4; Blue line with solid diamond: fed-batch line of S2; Blue line 
with unfilled diamond: fed-batch line of S4. 
 
7.4 Interfacial tension (IFT) analysis of Rhamnolipids 
 
7.4.1 IFT analysis of rhamnolipids produced by PEER02 strain. 
 
Like their chemical counterpart, biosurfactants also reduce interfacial tension between oil and 
water, thus decreasing the energy required to extract trapped oil in the porous matrix and displace 
this into the mobile liquid phase. But under what conditions can biosurfactants play a significant 
role in this process? How does one know when to expect biosurfactants to be a significant factor in 
some system under investigation? Here, rhamnolipids produced by P. aeruginosa PEER02 with 
soybean oil as carbon source was used to examine one of interfacial phenomena of biosurfactants -
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how rhamnolipids reduce interfacial tension and the effects of altering salt concentration, pH and 
temperature on rhamnolipids activity.  
First, we investigated the effects of different concentrations of rhamnolipids on IFT to find a 
suitable concentration for analyzing IFT of rhamnolipid in various conditions. All of these tests 
used n-octane as the hydrocarbon phase.  As shown in Figure 7-4-1a, the IFT of rhamnolipid 
solution rapidly decreases with an increase of rhamnolipid concentration. When the concentration 
exceeds the critical micelle concentration (CMC), the change of IFT becomes small.  According to 
the results of Figure7-4-1a, the CMC of our product is about 75mg/L. Hence, we selected 100ppm 
rhamnolipids for our subsequent IFT condition test.  
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 Figure 7-4-1. IFT analysis of PEER02 rhamnolipids in various conditions. (a) Profile of IFT of 
different concentration of rhamnolipids in water; (b) Effects of Salinity on IFT of rhamnolipids, 
Diamonds -  1% NaCl, Squares – 2% NaCl and  Triangles – 8% NaCl; (c) Effects of pH on IFT of 
rhamnolipids, Triangles – pH4, Squares – pH5 and  Diamonds -  pH6; (d) Effects of temperature on 
IFT of rhamnolipids, Diamonds – pH4, Squares – pH5 and  Triangles -  pH6. 
 
From Figure7-4-1b, we know that in the absence of additional salinity, rhamnolipids showed 
low IFT in the low pH buffer system, and in the range of pH 3-5, rhamnolipids showed the lowest 
IFT of about 0.3. If there is any additional salinity, the IFT profile is sensitive to pH.  For example, 
when 2% NaCl was added into rhamnolipids with pH5, the IFT of this solution decrease 
dramatically almost 5 fold. However, with the increase of salinity, not only the pH with lowest IFT 
will increase, but the absolute value of IFT also increases. In addition, IFT profile of rhamnolipid 
solution with same pH but different salinity will be greatly different. For pH6, the IFT will decrease 
with the increase of salinity. But for pH4, the behavior is the reverse. Increasing salinity resulted in 
IFT increase in the range of 0~10% NaCl. However, in pH5, there is an optimal salinity. Adding 
2% NaCl would show the lowest IFT for pH5 rhamnolipid solution (Figure 7-4-1c).  
Temperature is an important parameter for oil reservoir. Hence, temperature performance of 
rhamnolipid is indispensable when evaluating a product if you want to use it for enhancing oil 
recovery.  Our experiments showed that IFT only changed slightly (increased slightly) in the range 
of 30-90°C (Figure 7-4-1d).  
 
7.4.2  IFT analysis of the rhamnolipids produced from different substrates 
 
Rhamnolipids were produced with P. aeruginosa PEER02 from 12 different substrates, including 8 
plant oil, 2 sugars, two others, glycerol and ethanol.  The purified samples were applied for 
interfacial tension analysis agains n-Octane (Table 7). Geneally, the higher the percentage of di-
rhamnolipids with longer carbon chain was, the lower its IFT was. 
 
Table 7 IFT analysis of Rhamnolipids produced from various substrates 
No.      
Substrate 
(a) 6000rpm/30°C (b) 3000rpm/30°C 
mN/m 
@5min 
mN/m 
@10min 
mN/m 
@1min 
mN/m 
@5min 
mN/m 
@10min 
1 Soybean oil 5.486 4.989 0.280 0.149 0.077 
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 2 Corn oil 6.321 6.052 0.412 0.232 0.174 
3 Frying oil 6.367 6.190 0.520 0.331 0.253 
4 Palm oil 5.947 5.928 0.078 0.064 0.055 
5 Coconut oil 5.292 5.233 0.033 0.130 0.012 
6 Peanut oil 4.244 3.341 0.036 0.014 0.015 
7 Olive oil 5.021 5.007 0.088 0.053 0.037 
8 Grapeseed oil 5.050 5.012 0.181 0.111 0.061 
9   Glucose 5.737 5.955 0.138 0.140 0.128 
10 Glycerol 5.049 4.981 0.188 0.168 0.151 
11 Ethanol 2.498 2.439 0.040 0.022 0.011 
12 Fructose 5.942 4.976 0.430 0.418 0.413 
 
(a) dilute supernatant of fermentation to 100 ppm with distilled water  
(b) dilute supernatant of fermentation to 100 ppm buffer pH5 and 2% added NaCl 
 
7.4.3  Rhamnolipids produced by six Engineered strains Displayed Different Optimal IFT Values in 
Response to Different pH Conditions 
 
Rhamnolipid biosurfactants were fermented and adjusted to final concentration of 250ppm by oil 
spreading assay. Then the pH values were adjusted from 5 to 12 using two different buffer systems 
– citric acid wide range buffer system and boric acid universal buffer system. IFT values were then 
measured under each different pH conditions and plotted in Figure 7-4-2 and 7-4-3. In the citric 
acid based buffer system, the lowest IFT were obtained at PH 8 with the products of strain ETRA 
and ETRAC, white the lowest IFT of the products of other 4 strains were obtained at pH 7.  But in 
the Boric acid buffer system, the pH values of the lowest IFT were shifted downwards, with 
products of strain ETRA and ETRAC obtaining lowest IF at pH 7; and products of strain ETRhl, 
ETRABC and ETRhl-RC obtaining lowest IF at pH 7. The only exception was the product of strain 
ETRAB, which obtaining lowest IFT at pH7 in both buffer systems.  Figure 7-4-4 showed the 
effects of the salinity at pH7. The lowest IFT values for all six strains were obtained when 2% NaCl 
was added to the buffer. What surprised us was that even there were no detectable rhamnolipids 
produced by strain ETRA and ETRAC, their products produced very low IFT values.  
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Figure 7-4-2  IFT of 250ppm rhamnolipids produced by Engineered E.coli strains in the Citric acid 
buffer system. Dark blue squares: ETRA; Red triangles: ETRAB; Dark green circles: ETRhl; Light 
Bblue squares: ETRAC; Pink Triangles: ETRABC;  Light green circles: ETRhl-RC;  Open symbol : 
40mM Citric acid-Na2HPO4 wide range buffer (pH2.6-8.0); Solid symbol: 40mM Boric acid-KCl-
NaOH buffer (pH8.0-10.0); 
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Figure 7-4-3.  IFT of 250ppm rhamnolipids produced by Engineered E.coli strains in the C Boric 
acid approximate universal buffer system. Dark blue squares: ETRA; Red triangles: ETRAB; Dark 
green circles: ETRhl; Light Bblue squares: ETRAC; Pink Triangles: ETRABC;  Light green circles: 
ETRhl-RC. 
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Figure 7-4-4.  IFT of the rhamnolipids produced by six E.coli strains under different salinities. Dark 
blue squares: ETRA in pH8 40mM Citric acid-Na2HPO4 and 0-8% NaCl buffer;  Red triangles: 
ETRAB in pH7 40mM Citric acid-Na2HPO4 and 0-8% NaCl buffer; Dark green circles: ETRhl in 
pH7 40mM Citric acid-Na2HPO4 and 0-8% NaCl buffer  Light blue squares: ETRAC in pH8 
40mM Citric acid-Na2HPO4 and 0-8% NaCl buffer; Pink triangles: ETRABC in pH7 40mM Citric 
acid-Na2HPO4 and 0-8% NaCl buffer; Light green circles: ETRhl-RC in pH7 40mM Citric acid-
Na2HPO4 and 0-8% NaCl buffer  
 
 
7.5 Rhamnolipid production and divergent evolution in E.coli   
 
Rhamnolipids, as the entensively studied biosurfactants, were mainly produced from Pseudomonas 
aerugina or other Pseudomonads. Rhamnolipids production in Pseudomonads is a part of quorom 
sensing process, which has complex regulation.  Thus, optimizing production of rhamnolipids in  
Pseudomonads is quite difficult. In addition, many P. aeruginosa strains are pathogenic strains that 
are limited or not suitable for industrial applicatiion. E. coli, as generally recoginzed as safe 
(GRAS) microorgainsm, was comprehensively applied as engineered host strains for many 
bioproducts production, including proteins, enzymes, metabolites and other pharmaceuticals. 
The type of rhamnolipid produced depends on the bacterial strain, the carbon source used, 
and the process strategy (Mulligan et al., 1993). The lengths of the fatty acid chains of rhamnolipids 
can vary significantly, resulting in a multitude of different rhamnolipd compositions. Fatty acyl 
chains composed of 8, 10, 12, and 14 carbons in length, as well as 12- or 14-carbon chains with 
double bonds. The different structures of rhamnolipids resulted in different properties with respect 
to interfacial tension, solubility, and charge (Zhang and Miller, 1995). For example, the interfacial 
tension between hexadecane and water was decreased to <0.1 mN/m by the dR-Me (a methyl ester 
form of rhamnolipids) but was only decreased to 5 mN/m by the dR-A (the acid form of 
rhamnolipids). Solubilization and biodegradation of two alkanes in different physical states, liquid 
and solid, were determined at dirhamnolipid concentrations ranging from 0.01 to 0.1 mM (7 to 70 
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 mg/liter). The low product selectivity of rhamnolipids biosynthesis in bacteria showed that the key 
biosynthetic enzyme, here RhlAB, would function promiscuously (Khersonsky et al., 2006; James 
and Tawfik 2001). Many promiscuous functions of enzymes were proved to be susceptible to 
directed evolution.  Here, in to order to improve the performance of rhamnolipids from E coli 
directed evolution of RhlAB was investigated. 
From the biosynthetic pathway, the synthesis of rhamnolipids proceeds by sequential 
glycosyl transfer reactions, each catalyzed by a specific rhamnosyltransferase (rhamnosyltransferase 
1 or 2) with TDP-rhamnose acting as a rhamnosyl donor and 3-hydroxyalkanoyl-3-
hydroxyalkanoate acting as acceptor. L-rhamnosyl-3- hydroxyalkanoyl-3-hydroxyalkanoate (Rha-
Cm-Cn, m and n: 8, 10, 12, or 14) and L-Rhamnosyl-L- rhamnosyl-3-hydroxyalkanoyl-3-
hydroxyalkanoate (Rha-Rha-Cm-Cn) were referred to as rhamnolipids 1 (mono-rhamnolipids) and 2 
(di-rhamnolipds), respectively. Rhamnosyltransferase 1 is encoded by the RhlA and B (or RhlAB) 
genes, which are organized in an operon and responsible for biosynthesis of mono-rhamnolipds. 
The active enzyme complex is located in the cytoplasmic membrane, with the RhlA protein being 
localized in the periplasm and the catalytically active RhlB component crossing the membrane.  
Rhamnosyltransferase 2 is encoded by the RhlC gene that is located in an operon with an upstream 
gene (PA1131) of unknown in P. aeruginosa PAO1 and not organized with RhlAB. 
According to the metabolic engineering methodology for engineering rhamnolipid-
producing E. coli (Figure 7-5-1), various gene combinations were constructed (Figure 7-5-2) and 
transformed into E. coli BL21(DE3) to obtain the corresponding engineered strains which can 
produce either mono-rhamnolipids or  dirhamnolipids. The corresponding engineered strains and 
control strain were designated E. coli ETRA, ETRAC, ETRAB, ETRABC, ETRhl, ETRhl-RC and 
ET30, respectively. 
 
 
Figure 7-5-1. Diagram for Metabolic Engineering Methodology for Engineering Rhamnolipid-
producing E. coli 
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pET30a(+)
5422 bp
Kan
HindIII (174)
KpnI (239)
NcoI (213)
SacI (191)
EcoRI (193)
 
pETRhl-RC
10430 bp
Kan
RhlA
RhlB
RhlR
RhlI
RhlC
HindIII (1284)
NotI (167)
SacI (5199)
pETRhl
9320 bp
Kan
RhlB
RhlA
RhlI
RhlR
HindIII (174)
SacI (4089)
KpnI (437)
KpnI (4137)
pETRA
6272 bp
Kan
RhlA
EcoRI (193)
KpnI (1089)
pETRAC
7382 bp
RhlC
RhlA
Kan
EcoRI (1303)
HindIII (1284)
KpnI (2199)
NotI (167)
  
 
pETRAB
7601 bp
Kan RhlB
RhlA
HindIII (174)
KpnI (2418)
pETRAB-SacI
7608 bp
Kan RhlB (8)
RhlA
HindIII (174)
KpnI (2425)
SacI (1482)
NotI (167)
  
 
 Figure 7-5-2 Plasmid map for engineering rhamnolipid-producing E. coli. Parental plasmids 
pET30a(+) and Recombinant expression plasmids  
 
Preliminary fermentation of rhamnolids by engineered E. coli in rich (LB) or minimal (MS) media 
plus 0.4% glucose was carried out. The rhamnolipids yield and the IFT of their fermentative broth 
were shown in Table 8. 
  
 Table 8.  Preliminary fermentation of rhamnolids by engineered E. coli in rich (LB) or minimal 
(MS) media 
 
Strain                                       MS media                                                                         LB media 
                                      IFT(mN/m)       Rhamnolipid (mg/L)              IFT(mN/m)        Rhamnolipid (mg/L) 
 
E. coli ET30  40.1          <2               35.0         <5      
E. coli ETRA  5.8        75.0   0.015              190.0   
E. coli ETRAB 0.49  115.0   0.24        199.5 
E. coli ETRhl  0.76  125.0   0.30        231.5 
E. coli ETRAC 5.2005  83.3   0.013      253.8  
E. coli ETRABC        0.35  213.3   0.22       230.0   
E. coli ETRhl-RC 0.39  185.0   0.32105  235.0   
 
 
The IFT analysis and oil-spreading test indicate E. coli ETRA and E. coli ETRAC really produced 
some kind of biosurfactant, but TLC analysis showed (Fig 7-5-3) that they did not produce mono-
rhamnolipids and/or di-rhamnolipids (yellow dots). However, they do produce other kinds of 
compounds (purple dots) which need to be confirmed, e.g., LC-MS. E. coli ETRAB and ETRhl 
produced mono-rhamnolipids, and E. coli ETRABC and ETRhl-RC produced mono-rhamnolipids 
and di-rhamnolipids (Figure 7-5-4). The ratio of di/mono-rhamnolipids were approximately 
2:1~3:1.  
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              (a)             (b)            (c)              (d)            (e)             (f)               (g)   
Figure 7-5-3. Thin layer chromatography (TLC) of rhamnolipids from engineered E coli. (a) ETRA; 
(b) ETRAB; (c) ETRhl; (d) Commercial rhamnolipids (as standard); (e) ETRAC; (f) ETRABC; (g) 
ETRhl-RC. 
 
 
HPLC-MS analysis of these rhamnolipids further confirmed the structures of various surfactants 
from engineered strains (Figure 7-5-4).  Note for the ETRA and the ETRAC that the peaks are 
much lower than the other 4 samples, plus their elution times are shorter.  This further confirms that 
these 2 strains did not make rhamnolipid surfactants.   
 
 
(a) 
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(f) 
 
Figure 7-5-4. Base peak ion intensity chromatograms of rhamnolipids from various engineered E. 
coli strains. (a) ETRA; (b) ETRAB; (c) ETRhl; (d) ETRAC; (e) ETRABC; (f) ETRhl-RC. The main 
compositions are labeled in each chromatogram. 
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 Table 9.  Structure and relative abundance of the rhamnolipids from various engineered  
   E. coli 
   Strains Rha-Rha-C10-C10 
m/z 649 
Rha-C10-C10 
m/z 503 
Rha-Rha-C10-C12 
 (or C12-C10) m/z 677 
Rha-C8-C10 
 (or C10-C8) m/z 475 
E. coli ETRA - - - - 
E. coli ETRAB - 73.1 - 26.9 
E. coli ETRhl - 69.7 - 30.3 
E. coli ETRAC - - - - 
E. coli ETRABC 45.2 28.7 15.0 6.0 
E. coli ETRhl-RC 45.8 30.2 8.9 8.5 
   - denotes that it has no evidence of that chemical structure 
   
Directed evolution of RhlAB to improve rhamnolipids production in E. coli 
 
Mutant RhlA and RhlB genes were produced by error-prone PCR with  RhlA-21 (5’- 
AGTTGGTACCATGCGGCGCGAAAGTCTGTTGG -3’) and RhlA-22 (5’ 
TCAGGAGCTCTTATGCAACCGCAAAGCCCG-3’),  and RhlB21 (5’- 
GACGGAGCTCAAGAAGGAGATATACATATGCACGCCATCCTCATCGCCATC-3’) and 
RhlB-22 (5' -AACCAAGCTTTCAGGACGCAGCCTTCAGCCATCG - 3'). Muant RhlA or RhlB 
PCR products were digested with the corresponding restrictione enzymes (KpnI and SacI for RhlA; 
SacI and HindIII for RhlB) and cloned into pETRAB-SacI to replace wild-type genes of RhlA or 
RhlB. The mutants plamids were transformed into E. coli BL21(DE3) to produce a mutant library. 
  
To screen the mutant strains which have desire properties, a robust high throughput screening 
method should be developed. Here, we focused on panning the mutants which have high 
performance of interfacial tension from E. coli mutant library.  First, rhamnolipids from E. coli 
showed bioactivity  according to the results of plate methods (Figure 7-5-5a).  Filter disc containing 
rhamnolipids could effectively inhibit the growth of Bacillus subtilis cell and rhamnolipids with 
low interfacial tension have a larger clearing zone (Figure 7-5-5a, E2). Then, using a liquid culture 
method (Figure 7-5-5b, adding different rhamnolipids to diluted Bacillus subtilis cell culture), 
different rhamnolipids showed different the ability of inhibition (Figure 7-5-5c). 
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(a) 
 
 
 
(b) 
 
65 
 
  
(c) 
Figure 7-5-5.   Bioactive assay of rhamnolipids from E. coli. (a) Plate method; (b) Liquid culture  
            method, and (c) results.   This suggests a correlation of the plate results and IFT. 
 
Based on the results from the plate method and liquid culture method of bioactive assay of 
rhamnolipids, a high throughput screening method for primary screening mutants which can 
produce rhamnolipids with high performance of interfacial tension was developed (Fig 7-5-6).  
 
Figure 7-5-6.  Developing high throughput screening method to identify candidates with  
           improved rhamnolipids production in E coli. 
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 Mutant rhamnolipids characterization  
 
With this screening method, those mutants with the greatest inhibition for Bacillus subtilis cell 
growth were selected.  Then, mutant rhamnolipids were further screened through IFT measurement 
and structure analysis by HPLC/MS. Finally, one mutant which has mutation in RhlB (L168P, 
Figure 7-5-7) was confirmed to have different properties in IFT behavior and structure components 
(Figure 7-5-8 and Table 10) 
 
 
    50RHLB-WT
    50RHLB-MUTANT H
Consensus
MHAILIAIGSAGDVFPFIGLARTLKLRGHRVSLCTIPVFRDAVEQHGIAF
MHAILIAIGSAGDVFPFIGLARTLKLRGHRVSLCTIPVFRDAVEQHGIAF
mhailiaigsagdvfpfiglartlklrghrvslctipvfrdaveqhgiaf
   100RHLB-WT
   100RHLB-MUTANT H
Consensus
VPLSDELTYRRTMGDPRLWDPKTSFGVLWQAIAGMIEPVYEYVSAQRHDD
VPLSDELTYRRTMGDPRLWDPKTSFGVLWQAIAGMIEPVYEYVSAQRHDD
vplsdeltyrrtmgdprlwdpktsfgvlwqaiagmiepvyeyvsaqrhdd
   150RHLB-WT
   150RHLB-MUTANT H
Consensus
IVVVGSLWALGARIAHEKYGIPYLSAQVSPSTLLSAHLPPVHPKFNVPEQ
IVVVGSLWALGARIAHEKYGIPYLSAQVSPSTLLSAHLPPVHPKFNVPEQ
ivvvgslwalgariahekygipylsaqvspstllsahlppvhpkfnvpeq
   200RHLB-WT
   200RHLB-MUTANT H
Consensus
MPLAMRKLLWRCIERFKLDRTCAPEINAVRRKVGLETPVKRIFTQWMHSP
MPLAMRKLLWRCIERFKPDRTCAPEINAVRRKVGLETPVKRIFTQWMHSP
mplamrkllwrcierfk drtcapeinavrrkvgletpvkriftqwmhsp
   250RHLB-WT
   250RHLB-MUTANT H
Consensus
QGVVCLFPAWFAPPQQDWPQPLHMTGFPLFDGSIPGTPLDDELQRFLDQG
QGVVCLFPAWFAPPQQDWPQPLHMTGFPLFDGSIPGTPLDDELQRFLDQG
qgvvclfpawfappqqdwpqplhmtgfplfdgsipgtplddelqrfldqg
   300RHLB-WT
   300RHLB-MUTANT H
Consensus
SRPLVFTQGSTEHLQGDFYAMALRALERLGARGIFLTGAGQEPLRGLPNH
SRPLVFTQGSTEHLQGDFYAMALRALERLGARGIFLTGAGQEPLRGLPNH
srplvftqgstehlqgdfyamalralerlgargifltgagqeplrglpnh
   350RHLB-WT
   350RHLB-MUTANT H
Consensus
VLQRAYAPLGALLPSCAGLVHPGGIGAMSLALAAGVPQVLLPCAHDQFDN
VLQRAYAPLGALLPSCAGLVHPGGIGAMSLALAAGVPQVLLPCAHDQFDN
vlqrayaplgallpscaglvhpggigamslalaagvpqvllpcahdqfdn
   400RHLB-WT
   400RHLB-MUTANT H
Consensus
AERLVRLGCGMRLGVPLREQELRGALWRLLEDPAMAAACRRFMELSQPHS
AERLVRLGCGMRLGVPLREQELRGALWRLLEDPAMAAACRRFMELSQPHS
aerlvrlgcgmrlgvplreqelrgalwrlledpamaaacrrfmelsqphs
   426RHLB-WT
   426RHLB-MUTANT H
Consensus
IACGKAAQVVERCHREGDARWLKAAS
IACGKAAQVVERCHREGDARWLKAAS
iacgkaaqvverchregdarwlkaas  
 
Figure 7-5-7. Alignment of amino acid sequence of RhlB WT and Mutant H.  Mutant H has a  
single mutant at position L168P. 
 
 
 
67 
 
  
Rha-C10-C10 
Rha-C10-C8 
Rha-C8-C10
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Rha-Rha-C10 
Rha-C10-C8 
Rha-C8-C10
(b) 
Figure 7-5-8.  Base peak ion intensity chromatograms of rhamnolipids from engineered E. coli 
ETRAB-SacI WT and Mutant strains. (a) WT; (b) Mutant H. The main  compositions are labeled in 
each chromatogram.  Note for practical purposes, the ETRAB-SacI WT microbe is the same as 
ETRAB.  
 
Table 10.  IFT, structure and relative abundance of the rhamnolipids from E. coli ETRAB-SacI WT 
and Mutant strains 
Strains IFT (mN/m)* Rha-C10-C10** 
m/z 503 
Rha-C10-C8 
 m/z 475 
Rha-C8-C10 
 m/z 475 pH7 pH8 
WT 0.019 0.23 100 8.0 16.5 
Mutant H 0.22 0.018 100 11.5 3.7 
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* rhamnolipids concentration is 100mg/L, ** Given the relative amount of the Rha-C10-C10 100 
 
 7.6 Core flooding test of rhamnolipid for enhanced oil recovery 
 
7.6.1 Core flooding test of PEER02 rhamnolipid for enhanced oil recovery 
 
After an oil well loses its self flow (primary recovery by natural forces), and secondary flow 
(secondary recovery by pressurization using water flood and gas), approximately 2/3 of the original 
oil remains in the reservoir. Much of the remaining oil can be recovered by enhanced oil recovery 
techniques such as polymer flooding or surfactant flooding. Effective emulsifying surfactants and a 
better understanding of the formation of their emulsions with the crude oil are of paramount 
importance to economically recover the abundant residual oil in reservoirs. Entrapment of 
petroleum hydrocarbon by capillary forces is a major factor that limits oil recovery. Hydrocarbon 
displacement can occur if interfacial tension between the hydrocarbon and aqueous phases is 
reduced by several orders of magnitude. Microbial-produced biosurfactants may be an economical 
method to recover residual hydrocarbons since they are effective at low concentration. The IFT 
analysis of our engineered rhamnolipids showed that they can reduce remarkably interfacial tension 
of oil (n-octane)/water at the certain combination of higher salinity and acidic pH. Based on these 
data from IFT analysis, sand-packed core flooding tests of rhamnolipids from P. aeruginosa with 
soybean oil as carbon source were performed.  .  
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 Figure 7-6-1. Oil recovery test of sand-packed core by rhamnolipids flooding with 240 ppm of 
PEER02. (a) Profile of oil recovery and IFT during flooding; (b) Water cut and cumulative oil 
recovery. (I) rhamnolipid flooding; (II) Brine flooding. Water cut: is the percent of water phase in 
the effluent. 
 
Playground Sand purchased from Home Depot was packed into a 1” diameter by 2-foot long 
stainless steel tube to make a sand packed core. The sand pack was evacuated and saturated with 
brine. The brine composition and make-up brine for the rhamnolipid surfactant solution were the 
same as the pH5 buffer-2% NaCl brine – the conditions for minimum IFT.  The pore volume and 
porosity of this core were calculated, and also brine permeability of this core (approximately 50 
Darcies) was measured at different flow rates. Then, the brine was displaced with oil (n-Octane) in 
the core until no water (brine) comes out. The oil-saturated core was aged for 1 day at room 
temperature. After 1day aging, brine was injected to displace oil, and the oil production was 
recorded. Water injection continues until no oil comes out. Next, 3 PV of 250mg/L rhamnolipids 
solution was injected and then the core with rhamnolipids was shut in overnight at room 
temperature. On the next day, an additional 3 PV of 250mg/L rhamnolipids solution was injected, 
followed then by injection of 6 PV of the brine.  The recovered oil was measured and oil recovery 
change with injected pore volume of brine/rhamnolipids solution was calculated (Figure 7-6-1a and 
7-6-1b). 
 
Two-stage rhamnolipids flooding gave two peaks of oil recovery (Figure 7-6-1a).  The first 3 PV of 
rhamnolipids injection only gave a small amount of oil recovery, with a cumulative oil recovery of 
about 12% (Figure 7-6-1b). Then, another 3 PV of rhamnolipids was flooded following shut-in 
overnight. Then, a larger peak of oil recovery was noted (Figure 7-6-1a), and by the end of this 
stage, the cumulative oil recovery reached 37% (Figure 7-6-1b). After rhamnolipids injection and 
displacement by a 6 PV brine flush, the final cumulative oil recovery reached 42% (Figure 7-6-1b). 
The profile of IFT of the effluent shows IFT decreased with oil recovery.  At the point of maximum 
oil cut, the lowest IFT was observed.  Thereafter, with lower oil cut, IFT increased, and then 
maintained a relatively stable level. The subsequent brine flooding made IFT of the effluent 
increase yet further. This is because the concentration of rhamnolipids decreased with brine 
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 flooding. Our flooding technology showed that overnight incubation of core with rhamnolipids 
would increase oil recovery effectively and reduce the water cut.  
 
After an oil well loses its self flow (primary recovery by natural forces), and secondary flow 
(secondary recovery by pressurization using water flood and gas), approximately 2/3 of the original 
oil remains in the reservoir. Much of the remaining oil can be recovered by enhanced oil recovery 
techniques such as polymer flooding or surfactant flooding. Effective emulsifying surfactants and a 
better understanding of the formation of their emulsions with the crude oil are of paramount 
importance to economically recover the abundant residual oil in reservoirs. Entrapment of 
petroleum hydrocarbon by capillary forces is a major factor that limits oil recovery. Hydrocarbon 
displacement can occur if interfacial tension between the hydrocarbon and aqueous phases is 
reduced by several orders of magnitude. Microbial-produced biosurfactants may be an economical 
method to recover residual hydrocarbons since they are effective at low concentration. The IFT 
analysis of our engineered rhamnolipids showed that they can reduce remarkably interfacial tension 
of oil (n-octane)/water at the certain combination of higher salinity and acidic pH. Based on these 
data from IFT analysis, sand-packed core flooding tests of rhamnolipids from P. aeruginosa with 
soybean oil as carbon source were performed.  .  
 
7.6.2 Sand-packed Core Flooding Tests Showed that only Strains Produced Rhamnolipids that were 
Detected by LC-MS can Recover Oil Effectively 
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The fermentation products of the each engineered E.coli strains were adjusted to 250ppm based on 
oil spreading assay and their optimal pH which gives the lowest IFT value. Each of those solutions 
was then tested for its oil recovery capability by the Sand-packed Core Flooding experiments and 
the results were summarized in Figure 7-6-2 to Figure 7-6-3.  The strains ETRhl, ETRABC and 
ETRhl-RC, which can produce rhamnolipids according to table 2 in Section 3.4, could effectively 
recover 24-45% of the remaining oil after water flooding. While the products of the strains ETRA 
and ETRAC, which did not produce LC-MS detectable rhamnolipids, could not recover oil 
effectively. Thus, although those two strains produced some surface-active products that gave low 
IFT values, they could not recover oil nearly as well as the strains that produced either mono or di- 
rhamnolipid biosurfactants. Apparently, the oil recovery efficiency is closely correlated to the IFT 
 
 values (Figure 7-6-3). Interestingly, strain ETRAB could produce rhamnolipids in good quantity, 
but it recovered least amount of oil among the six E.coli strains. It seemed that the high adsorption 
of the rhamnolipids produced by ETRAB could be the contributing factor of its low oil recovery 
(Figure 7-6-4).  Summary of the surfactant adsorption of the fermentation products of the six E.coli 
strains.). Further experiments need to be conducted to investigate the difference between ETRAB 
and other stains that contain rhamnosyltransferase-B gene.   
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Figure 7-6-2.  Sand-packed core flooding tests of the rhamnolipids produced by six engineered E.coli strains. 
Rhamnolipids were adjusted to 250ppm and optimal pH values based on the IFT tests.  Blue diamonds – 
ETRA; Pink Squares-  ETRAB; Yellow triangles – ETRhl; Light blue crosses – ETRAC; Brown stars – 
ETRABC and Brown circles – ETRhl-RC.  
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 Figure 7-6-3.  Summary of the remaining oil recovery and IFT of the initial rhamnolipids injected of the 
fermentation products of the six E.coli strains.  
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Figure 7-6-4.  Summary of the surfactant adsorption of the fermentation products of the six E.coli 
strains. 
 
8.  Research work during the no-cost extension period (Year 3) 
 
Rhamnolipids, as the extensively studied biosurfactants, are a subclass of glycolipids and mainly 
produced from Pseudomonas aerugina. Besides the comprehensive application in environmental 
engineering, rhamnolipids also have potential application in medicine, such as from their 
antimicrobial activity and anti-adhesive activity.  Rhamnolipids production in Pseudomonads is 
involved in the process of quorum sensing with complex regulation and quite difficult for 
optimization. In addition, many P. aeruginosa strains are pathogenic strains that are limited or not 
suitable for industrial development. Here, through the methodology of synthetic biology and 
metabolic engineering, E. coli was designed to produce mono-rhamnolipids by introducing the key 
genes of rhamnolipid biosynthesis, RhlAB.  
 
Usually, the type of rhamnolipids produced depends on the bacterial strain, the carbon source used, 
and the process strategy (Mulligan et al., 1993). Due to the structure diversity of rhamnolipid, here, 
we used directed evolution technology to improve rhamnolipid production in engineered E. coli. 
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 Using high-throughput screening method based on bioactive assay a mutant with different product 
selectivity was found. Oil recovery test was carried with rhamnolipid samples from wild type strain 
and mutant at different condition to evaluate the performance the different rhamnolipid samples. 
 
8.1 Plasmid-based engineered bacteria were constructed for rhamnolipid production 
Rhamnolipids production in Pseudomonads is a part of quorom sensing process, which is 
complicately regulated. Thus, optimizing production of rhamnolipids in  Pseudomonads is quite 
difficult. In addition, many P. aeruginosa strains are pathogenic strains that are limited or not 
suitable for industrial applicatiion. E. coli, as generally recoginzed as safe (GRAS) microorgainsm, 
was comprehensively applied as engineered host strains for many bioproducts production, including 
proteins, enzymes, metabolites and other pharmaceuticals. According to the metabolic engineering 
methodology for engineering rhamnolipid-producing E. coli, RhlAB genes were constructed under 
T7 promoter (Figure 8-1-1) and transformed into E. coli BL21(DE3) to obtain the corresponding 
plasmid-based engineered strain E. coli ETRAB which can produce either mono-rhamnolipids 
(Table 11). Preliminary fermentation of rhamnolids by engineered E. coli in minimal (MS) media 
plus 0.4% glucose was carried out (Table 11). The E. coli ET30 containing pET30a(+) was a 
control strain. For the subsequent experiment of directed evolution, we also introduce a site of SacI 
between RhlA and RhlB. Thus, we obtained another rhamnolipid-producing strain E. coli ETRAB-
SacI. The rhamnolipids from this strain is same as that from E. coli ETRAB (Table 11) 
 
Table 11 Production, structure and relative abundance of the rhamnolipids from various plasmid-
based engineered E. coli 
 Strains Rhamnoli
pid 
(mg/L) 
Type of 
Rhamno
lipid 
Rha-Rha-
C10-C10 
m/z 649 
Rha-C10-
C10 
m/z 503 
Rha-Rha-C10-
C12 
 (or C12-C10) 
m/z 677 
Rha-C8-C10 
 (or C10-C8) 
m/z 475 
E. coli ET30 ND - - - - - 
E. coli ETRAB 
115.0±14.
2 Mono- - 73.1 - 26.9 
E. coli ETRAB-
SacI 
120.0±15.
1 Mono- - 69.7 - 30.3 
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 ND: can’t detect. The media for rhamnolipid production is minimal salt plus 0.4% glucose. The 
fermentation condition is 30°C and 24h with shaking. LB media was the media for seed culture. 
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Figure 8-1-1. Plasmid map for engineering rhamnolipid-producing E. coli. Parental plasmid is 
pET30a(+). RhlA: Rhamnosyltransferase Gene A; RhlB:Rhamnosyltransferase Gene B. 
 
8.2 Oil recovery test of rhamnolid from engineered strain with Limestone core in Amott cell 
 
From the result of directed evolution for improved rhamnolipid production, we have found the 
rhamnolipid from a mutant which showed different IFT performance at different pH compared with 
that from wild-type strain (Table 12). Our final goal to engineering strains for improving 
rhamnolipid is to apply them in EOR.  To evaluate the performance of our rhamnolipid samples, we 
designed a simple oil recovery test with limestone core at Amott cell (Figure 8-2-1). Briefly, the 
1×2 inch cores (a slab of limestone obtained by New Mexico Travertine) were at 120°C for hours to 
remove adsorbed moisture, vacuumed for 4 hours to remove the air inside of core, and saturated 
with n-octane containing 0.05% red ink dye overnight. The cores were weighed before and after oil 
saturation, and the amount of adsorbed oil in the cores were recorded.  Then, the n-octane-saturated 
cores were placed in Amott cell containing 200ppm rhamnolipid solution in 50 mM Citrate-
Na2HPO4 buffer, pH7 or pH8, and the oil was measured that came out the volumetric burette of 
Amott cell (As the aqueous phase imbibes into the core, oil expelled and captured in the volumetric 
burette. The Amott cell was maintained at room temperature and the oil recovery was monitored 
versus time (Figure 8-2-1).  
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Figure 8-2-1. Oil recovery test with Limestone core at Amott cell. Open dark square: wild-type 
sample at pH7; Open red square; mutant sample at pH7; Filled dark square: wild-type sample at 
pH8; Filled red square: mutant sample at pH8. 
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Figure 8-2-2. The relationship of IFT and Oil recovery from Limestone core at Amott cell. 
 
From the results of oil recovery test with limestone core at Amott cell, we found that if the 
rhamnolipid showed lower IFT at the test condition, higher oil recovery was reached. For example, 
at pH7, the rhamnolipid sample from wild-type strain E. coli ETRAB-SacI WT had the lower IFT 
of 0.039mM/m, and the oil recovery in this condition at Amott cell was 35.6% after 24h. At pH8, 
the sample from mutant strain H had the lower IFT of 0.019mN/m, and oil recovery 42.2%. From 
these four oil recovery tests, we made a plot of the relationship of IFT and oil recovery (Figure 8-2-
2). It seems that a linear trend was presented. The lower IFT is, the more oil is recovered by 
imbibition. 
 
76 
 
 8.3 Global transcriptional machinery engineering for improving rhamnolipid production in 
Escherichia coli 
 
Engineering transposon-based E. coli for rhamnolipid production 
From the biosynthetic pathway (Figure 8-3-1), the synthesis of rhamnolipids proceeds by sequential 
glycosyl transfer reactions, each catalyzed by a specific rhamnosyltransferase with TDP-rhamnose 
acting as a rhamnosyl donor and 3-hydroxyalkanoyl-3-hydroxyalkanoate acting as acceptor. L-
Rhamnosyl-L-rhamnosyl- 3-hydroxyalkanoyl 3-hydroxyalkanoate and L-rhamnosyl-3-
hydroxyalkanoyl-3- hydroxyalkanoate, referred to as rhamnolipids 1 (mono-rhamnolipids) and 2 
(di-rhamnolipds), respectively, are the principal glycolipids produced in liquid cultures. 
Rhamnosyltransferase 1 is encoded by the rhlAB genes, which are organized in an operon and 
responsible for biosynthesis mono-rhamnolipds. The active enzyme complex is located in the 
cytoplasmic membrane, with the RhlA protein being localized in the periplasm and the catalytically 
active RhlB component crossing the membrane (Ochsner et al., 1994).  
 
RhlAB was the key enzyme of rhamnolipids biosynthesis, but this biosynthesis was modulated by 
the complex transcriptional regulatory network in P. aeruginosa (Soberon-Chavez and Aguirre-
Ramirez, 2005). However, to achieve the rhamnolipids production in the strains which can not 
produce rhamnolipids, integrating RhlAB is indispensable. In this circumstance, convenient 
molecular biotechniques would give good success.  Here, we show an improvement via the state-of-
the-art transposome-mediated chromosomal integration to modify metabolic pathway of 
rhamnolipid biosynthesis.  
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Briefly, RhlAB coding region which was fused with T7 promoter and selection maker gene Cm 
(chloramphenicol resistance gene) were cloned into Tn5 derived transposon plamid pMOD-2 
(Epcentre Biotechnologies, Madison, WI) to produce the recombinant plasmid pMOD-2CRABb 
(Wang et al., 2007). pMOD-2CRABb was digested with PshAI to obtain chimeric transposon 
TnRABb (Figure 8-3-1a) which can bind transposase to produce transposome TnRABbsome 
(Figure 8-3-1b).  This new transposon TnRAB was inserted into the chromosome of E. coli 
BL21(DE3) by transposome-mediated integration to engineer strain E. coli TnERAB which was 
also confirmed by PCR (data not shown). With IPTG induction, E. coli TnERAB can produce 
 
 rhamnolipid both in rich (LB) and minimal (MS) media and glucose as substrate. Because E. coli 
can grow better in LB media than minimal media, rhamnolipid yield is higher in LB media (Table 
12).  
P 
Tn5 Inverted 
repeat 
Tn5 Inverted 
repeat 
Cm RhlB RhlA 
(B) 
(A) 
(C) 
 
Figure 8-3-1. Diagram of Engineered Rhamnolipids-producing E. coli Construction 
(a) Structure of rhamnolipid biosynthetic gene RhlAB-containing Transposon TnRAB); Cm: 
chloramphenicol resistance gene cassette; P: T7 promoter; (b) Transposome TnRABsome 
construction; (c) Transposome eletroevaporation and insertion mutants selection.  
 
Table 12 Rhamnolipid fermentation by engineered E. coli in rich or minimal media 
Stains Rhamnolipid (mg/L) 
LB plus 0.4% glucose MS plus 0.4% glucose 
E. coli BL21(DE3) ND ND 
E. coli TnERAB 175.3±13.2 75.6±11.2 
          ND: can’t detect 
 
 
Global transcriptional machinery engineering for improving rhamnolipid production 
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 Prior efforts in metabolic engineering have attempted to improve strain properties through the 
modification of components of localized pathways and certainly using gene-by-gene strategies. To 
this end, many successful examples have been reported that were based on re-designing regulatory 
networks, metabolite balancing systems, and rational or combinatorial gene deletion and 
amplification approaches. However, these approaches lack a cell-wide perspective and mostly fail 
in eliciting desired phenotypes dependent on simultaneous multiple gene modifications. A central 
reason is the vast size of the space of possible combinations of multiple-gene modifications 
combined with limited transformation capacity needed to probe this space. As a result, a huge 
fraction of the phenotype space that depends on multiple gene interactions has been largely 
unexplored. 
Here, we present a method that departs from the traditional gene-phenotype mapping 
approach and regards the phenotype as the manifestation of a particular transcriptional profile. 
Hence, the method attempts to elicit new phenotypes by manipulating directly the transcriptome of 
a cell through engineering of specially selected global regulators. This approach allows modulation 
of simultaneous multiple gene expression at the highest level with profound implications for 
phenotype improvement of prokaryotic and eukaryotic cells alike. Specifically, we modify the 
sigma factors σ70 (RpoD) of Escherichia coli to elicit a possible multigenic reprogramming of the 
transcriptome using an approach termed global Transciption Machinery Engineering (gTME).  
RpoD with native promoter was amplified by error-prone PCR, digested with NheI/HindIII, and 
cloned into low-copy-number plasmid pACYC177. The recombinant plasmids were transformed 
rhamnolipid-producing strain E. coli TnERAB to create a mutant library. The mutants were applied 
for screening after plating in the blood agar (Figure 8-3-2). The mutant colonies which formed the 
largest clearing zone on blood agar were picked out and followed to further analysis of rhamnolipid 
production by fermentation. After two rounds of screening with blood agar and fermentation, a 
mutant with enhanced yield was found. This mutant (E. coli TnERAB-45II harboring pArpoD-45II) 
can produce 263.9mg/L rhamnolipid in LB plus 0.4% glucose at 30°C for 24 hours. Compared with 
the rhanmolipid yield of wild type strain E. coli TnERAB-WT harboring pArpoD-WT, the yield of 
mutant strain has 1.5-fold higher in the same fermentation condition. 
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Figure 8-3-2. Construction of mutant library of RpoD by error-prone PCR.  
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Figure 8-3-3. Alignment of amno acid sequence of RpoD WT and Mutant 45II. Mutant H have two-
point mutation, G398D and Q437R. 
Aligning the protein sequence of wild-type and mutant sigma factors σ70 (RpoD), we found 
that there are two point mutation in mutant protein, G398D and Q437R (Figure 8-3-3). These 
mutations will lay a foundation for our further engineering of strains to improve rhamnolipid 
production in E. coli and elucidate the mechanism of yield enhancement. 
 
9.  Milestones Status 
During this three-year of study, we have met the following milestones for the project: 
1.  The genes involved in the rhamnolipid bio-synthesis were successfully cloned.  
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 2.  By using the Transposon containing Rhamnosyltransferase gene rhlAB, we have successfully 
produced rhamnolipds in both P. aeroginosa PAO1-RhlA- strain and P. fluorescens ATCC15453 
strain, with the increase of 55 to 175 fold in rhamnolipid production comparing with wild type 
bacteria strain.  
3. We have completed several rounds of direct evolution studies and have constructed the library of 
RhlAB-containing Transposon to express mutant gene in heterologous hosts. 
4. The comprehensive evaluation studies of rhamnolipid as a surfactant product for conventional 
chemical EOR applications were completed.  
5. We are continuing to improve lab methods to clone a bio-surfactant mutant into candidate 
thermophilic oil field microbes.  
6. We have successfully engineered P. aeruginosa PEER02 strain and several E. Coli strains and 
mutants to produce rhamnolipid biosurfactants effectively.  
 
10.  Summary of Significant Accomplishments  
1.  We successfully engineered the new mutant strains P. aeruginosa PEER02 and E. coli TnERAB 
that can produce rhamnolipids. 
2.  Rhamnolipid biosurfactants produced by our engineered bacteria have been evaluated by core 
flooding tests and are proven to be effective EOR agent  
3. We have successfully produced rhamnolipids from many different plant oils and other agriculture 
products and waste products. 
4. A Bioactive assay based on a high throughput screening method for screening our mutants and 
improving rhamnolipids production in E coli was successfully developed. 
5. A complete LC-MS analytical methods have been documented for structural analysis of the  
rhamnolipids. 
 
11. Future Work / Potential Problems 
If funds are available, we will continue our research into following directions, 
1. Further improve the methods to evaluate rhamnolipid and surfactin for their EOR characteristics. 
2. Improve our mutant strains and optimize fermentation process to increase the yield of 
rhamnolipid production using agriculture products and waste streams as substrate. 
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 3. Continue our directed evolution studies, screen and improve our mutant E.Coli strains to produce 
rhamnolipids with different structural verities.   
4. Continue to search for better oilfield microbe strains that could be a carrier of our improved 
mutant genes for potential in-situ oilfield EOR applications. 
 
12. Technology Transfer Activities 
We have discussed our research work and potential technology value with several major oil 
companies, such as Chevron, Exxon-Mobil and Shell. We also presented some of our research 
results as a poster at the 28th Symposium on Biotechnology for fuels and Chemicals in Nashville, 
TN in May 2006, the SPE Oilfield Chemistry Symposium in Feb, 2007, and the AIChE 2007 
Annual Meeting.  
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